<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Mol. Neurosci.</journal-id>
<journal-title>Frontiers in Molecular Neuroscience</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Mol. Neurosci.</abbrev-journal-title>
<issn pub-type="epub">1662-5099</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fnmol.2017.00283</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>RNA-Sequencing Analysis Reveals a Regulatory Role for Transcription Factor <italic>Fezf2</italic> in the Mature Motor Cortex</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Clare</surname> <given-names>Alison J.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/427793/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Wicky</surname> <given-names>Hollie E.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/446456/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Empson</surname> <given-names>Ruth M.</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/102535/overview"/>
</contrib> 
<contrib contrib-type="author" corresp="yes">
<name><surname>Hughes</surname> <given-names>Stephanie M.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="author-notes" rid="fn001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/102724/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Biochemistry, School of Biomedical Sciences, University of Otago</institution> <country>Dunedin, New Zealand</country></aff>
<aff id="aff2"><sup>2</sup><institution>Brain Health Research Centre, University of Otago</institution> <country>Dunedin, New Zealand</country></aff>
<aff id="aff3"><sup>3</sup><institution>Genetics Otago, University of Otago</institution> <country>Dunedin, New Zealand</country></aff>
<aff id="aff4"><sup>4</sup><institution>Department of Physiology, School of Biomedical Sciences, University of Otago</institution> <country>Dunedin, New Zealand</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Michael J. Schmeisser, Otto von Guericke University of Magdeburg, Germany</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Christoph Wiegreffe, University of Ulm, Germany; Subhabrata Sanyal, California Life Company (Calico), United States</p></fn>
<fn fn-type="corresp" id="fn001"><p>&#x0002A;Correspondence: Stephanie M. Hughes <email>stephanie.hughes&#x00040;otago.ac.nz</email></p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>07</day>
<month>09</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>10</volume>
<elocation-id>283</elocation-id>
<history>
<date date-type="received">
<day>28</day>
<month>06</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>22</day>
<month>08</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2017 Clare, Wicky, Empson and Hughes.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>Clare, Wicky, Empson and Hughes</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract><p><italic>Forebrain embryonic zinc finger</italic> (<italic>Fezf2</italic>) encodes a transcription factor essential for the specification of layer 5 projection neurons (PNs) in the developing cerebral cortex. As with many developmental transcription factors, <italic>Fezf2</italic> continues to be expressed into adulthood, suggesting it remains crucial to the maintenance of neuronal phenotypes. Despite the continued expression, a function has yet to be explored for <italic>Fezf2</italic> in the PNs of the developed cortex. Here, we investigated the role of <italic>Fezf2</italic> in mature neurons, using lentiviral-mediated delivery of a shRNA to conditionally knockdown the expression of <italic>Fezf2</italic> in the mouse primary motor cortex (M1). RNA-sequencing analysis of <italic>Fezf2</italic>-reduced M1 revealed significant changes to the transcriptome, identifying a regulatory role for <italic>Fezf2</italic> in the mature M1. Kyoto Encyclopedia Genes and Genomes (KEGG) pathway analyses of <italic>Fezf2</italic>-regulated genes indicated a role in neuronal signaling and plasticity, with significant enrichment of neuroactive ligand-receptor interaction, cell adhesion molecules and calcium signaling pathways. Gene Ontology analysis supported a functional role for <italic>Fezf2</italic>-regulated genes in neuronal transmission and additionally indicated an importance in the regulation of behavior. Using the mammalian phenotype ontology database, we identified a significant overrepresentation of <italic>Fezf2</italic>-regulated genes associated with specific behavior phenotypes, including associative learning, social interaction, locomotor activation and hyperactivity. These roles were distinct from that of <italic>Fezf2</italic>-regulated genes identified in development, indicating a dynamic transition in <italic>Fezf2</italic> function. Together our findings demonstrate a regulatory role for <italic>Fezf2</italic> in the mature brain, with <italic>Fezf2</italic>-regulated genes having functional roles in sustaining normal neuronal and behavioral phenotypes. These results support the hypothesis that developmental transcription factors are important for maintaining neuron transcriptomes and that disruption of their expression could contribute to the progression of disease phenotypes.</p></abstract>
<kwd-group>
<kwd><italic>Fezf2</italic></kwd>
<kwd>RNA-seq</kwd>
<kwd>motor cortex</kwd>
<kwd>mouse</kwd>
<kwd>lentivirus</kwd>
<kwd>shRNA</kwd>
</kwd-group>
<counts>
<fig-count count="5"/>
<table-count count="2"/>
<equation-count count="0"/>
<ref-count count="65"/>
<page-count count="14"/>
<word-count count="9549"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="introduction" id="s1">
<title>Introduction</title>
<p>The pyramidal projection neurons (PNs) of the mature cortex display vast diversity in their phenotypes and connections (Molyneaux et al., <xref ref-type="bibr" rid="B41">2007</xref>; Spruston, <xref ref-type="bibr" rid="B57">2008</xref>). These excitatory PNs encode messages that are critical for mediating higher cognitive function and behavioral output (Spruston, <xref ref-type="bibr" rid="B57">2008</xref>). Often neurodegenerative disease preferentially affects specific neuronal subtypes, regardless of a universal role for the causative factors (Yang et al., <xref ref-type="bibr" rid="B66">2014</xref>), highlighting that vulnerability can be unique to specific PN types. Therefore, broadening our knowledge of the regulatory factors that maintain neuronal function and diversity is critical to our understanding of the brain in health and disease.</p>
<p>Spatially restricted expression of transcription factors play an important role in directing the fate of distinct PN types in the cortex (Arlotta et al., <xref ref-type="bibr" rid="B4">2005</xref>; Chen J.-G. et al., <xref ref-type="bibr" rid="B10">2005</xref>; Chen B. et al., <xref ref-type="bibr" rid="B9">2005</xref>; Molyneaux et al., <xref ref-type="bibr" rid="B40">2005</xref>; Alcamo et al., <xref ref-type="bibr" rid="B2">2008</xref>; Britanova et al., <xref ref-type="bibr" rid="B8">2008</xref>; McKenna et al., <xref ref-type="bibr" rid="B39">2011</xref>; Kwan et al., <xref ref-type="bibr" rid="B30">2012</xref>; Lodato et al., <xref ref-type="bibr" rid="B35">2014</xref>) and many have continued expression into adulthood (Inoue et al., <xref ref-type="bibr" rid="B26">2004</xref>; Ozdinler et al., <xref ref-type="bibr" rid="B44">2011</xref>; Deneris and Hobert, <xref ref-type="bibr" rid="B13">2014</xref>; Zeisel et al., <xref ref-type="bibr" rid="B68">2015</xref>). This raises the intriguing possibility that these factors play a role in maintaining adult neuronal identity. Certainly, recent studies in mammalian models have demonstrated roles for developmentally important transcription factors in maintaining several distinct neuronal subtypes (Kadkhodaei et al., <xref ref-type="bibr" rid="B28">2009</xref>; Liu et al., <xref ref-type="bibr" rid="B33">2010</xref>; Tsarovina et al., <xref ref-type="bibr" rid="B61">2010</xref>; Song et al., <xref ref-type="bibr" rid="B56">2011</xref>; Domanskyi et al., <xref ref-type="bibr" rid="B17">2014</xref>). For example, the conditional knockdown of <italic>Nurr1</italic>, a key transcription factor for differentiation of midbrain dopaminergic neurons, resulted in a loss of midbrain dopaminergic neurons and striatal dopaminergic neuronal markers in the adult brain, accompanied by impaired motor behavior (Kadkhodaei et al., <xref ref-type="bibr" rid="B28">2009</xref>). The developmental transcription factor, <italic>Pet-1</italic>, is required for 5-HT synthesis in the adult brain and conditional knockout of <italic>Pet-1</italic> elevates anxiety behaviors in mice (Liu et al., <xref ref-type="bibr" rid="B33">2010</xref>). Results such as these highlight the clinical implications of understanding maintenance of neuronal identity. However, despite the importance the cortex has for mediating higher-cognitive behavior, there has been no investigation of the potential regulatory factors maintaining neuronal diversity within the cortex.</p>
<p>During development, highly organized expression of transcription factors are essential to ensure the correct specification of PN types in the layered structure of the cortex (Arlotta et al., <xref ref-type="bibr" rid="B4">2005</xref>; Han et al., <xref ref-type="bibr" rid="B21">2011</xref>; Kwan et al., <xref ref-type="bibr" rid="B30">2012</xref>; Srinivasan et al., <xref ref-type="bibr" rid="B58">2012</xref>). One such transcription factor, <italic>Forebrain embryonic zinc finger 2</italic> (<italic>Fezf2</italic> also known as <italic>Zfp312, Fezl, Znf312</italic>), is expressed in the deep layer PNs (layer 5 and 6), where it is critical to the specification of corticospinal projection neurons (CSpPNs; Chen J.-G. et al., <xref ref-type="bibr" rid="B10">2005</xref>; Molyneaux et al., <xref ref-type="bibr" rid="B40">2005</xref>). The restricted expression of <italic>Fezf2</italic> persists into adulthood (Inoue et al., <xref ref-type="bibr" rid="B26">2004</xref>; Ozdinler et al., <xref ref-type="bibr" rid="B44">2011</xref>; Tantirigama et al., <xref ref-type="bibr" rid="B59">2016</xref>), where high levels of expression in layer 5 were thought to be a CSpPN specific marker (Ozdinler et al., <xref ref-type="bibr" rid="B44">2011</xref>). However, recent work found that <italic>Fezf2</italic>-expression identifies a diverse group of PNs in layer 5 of the mature primary motor cortex (M1; Tantirigama et al., <xref ref-type="bibr" rid="B59">2016</xref>). These comprised of intratelencephalic projection neurons (IT-PNs), which are affected in disorders such as schizophrenia (Shepherd, <xref ref-type="bibr" rid="B71">2013</xref>) and pyramidal tract projection neurons (PT-PNs), including CSpPNs that are lost in the progression of amyotrophic lateral sclerosis (ALS; Ozdinler et al., <xref ref-type="bibr" rid="B44">2011</xref>). The diversity of <italic>Fezf2</italic> expression within layer 5 of M1 makes it an interesting target to investigate for the maintenance of layer-specific PNs in the adult cortex, with the potential to identify target factors with broad clinical implications.</p>
<p>Here, we explored a role for <italic>Fezf2</italic> in maintaining the molecular profiles of mature neurons in the mouse M1. The effects of lentiviral-mediated conditional knockdown of <italic>Fezf2</italic> in the mature M1 were analyzed by RNA-sequencing. We found significant changes in gene expression demonstrating a functional role for <italic>Fezf2</italic> in the mature brain. Through comparison to <italic>Fezf2</italic>-regulated genes previously identified in development (Lodato et al., <xref ref-type="bibr" rid="B35">2014</xref>), we discovered a distinct transition in <italic>Fezf2</italic> function. Bioinformatic analyses of the differentially expressed genes in mature M1 revealed a functional role for <italic>Fezf2</italic> in the regulation of ion flux and cell signaling. In particular, we found <italic>Fezf2</italic> regulates an enrichment of genes important to the functional phenotypes of <italic>Fezf2</italic>-expressing neurons, including genes that regulate calcium transport at the cell membrane. Gene expression changes additionally implicate <italic>Fezf2</italic> in regulating molecular expression profiles that are known to be important for the regulation of behavior. Together, these findings demonstrate an importance for <italic>Fezf2</italic> in maintaining functionally important molecular expression profiles in the mature brain, distinct from its role in development.</p>
</sec>
<sec sec-type="materials and methods" id="s2">
<title>Materials and Methods</title>
<sec id="s2-1">
<title>Mice</title>
<p>All experiments were performed with male Swiss-Webster mice of either wild-type (non-transgenic) or hemizygous transgenic (Zfp312-EGFP)CO61GsatMmnc mouse line (Gong et al., <xref ref-type="bibr" rid="B19">2003</xref>) bred on a Swiss-Webster background strain. The transgenic mice express green fluorescence protein (GFP) under the control of <italic>Fezf2</italic> regulatory elements and are referred to from here on as <italic>Fezf2-Gfp</italic> mice. All animal husbandry, surgical procedures and use of animal tissue was approved by the University of Otago Animal Ethics Committee and the use of lentivirus (LV) in the mouse brain (<italic>in vivo</italic>) was approved by the Environmental Protection Authority (EPA), New Zealand under approval number GMD002851.</p>
</sec>
<sec id="s2-2">
<title>Lentiviral Vector Packaging</title>
<p>Lentiviral vectors were generated with approval from the EPA (GMD002849). The mouse <italic>Fezf2 shRNA</italic> and <italic>non-silencing shRNA</italic> were purchased from Open Biosystems (GE Healthcare, Dharmacon, CO, USA) and cloned into a HIV-1 derived lentiviral expression construct (Desmaris et al., <xref ref-type="bibr" rid="B14">2001</xref>) downstream of a rat <italic>Synapsin I</italic> 1.1 kb promoter fragment (Dittgen et al., <xref ref-type="bibr" rid="B16">2004</xref>) and mCherry reporter gene (<italic>pLV.SynI.mCherry.Fezf2shRNA</italic> or <italic>non-silencing shRNA</italic>). The <italic>shRNA</italic> sequences are flanked by endogenous mir-30 sequences, allowing both mCherry and <italic>shRNA</italic> to be transcribed by a Pol-II promoter (Fellmann et al., <xref ref-type="bibr" rid="B18">2013</xref>), in this case <italic>SynI</italic>.</p>
<p>The lentiviral constructs were packaged using a second generation packaging system (Zufferey et al., <xref ref-type="bibr" rid="B70">1997</xref>). Briefly, HEK293FT cells were plated at 5.4 &#x000D7; 10<sup>6</sup> cells per T75 flask and transfected with 18.6 &#x003BC;g shRNA-expressing construct, 9.6 &#x003BC;g <italic>psPAX2</italic> (gifted from Didier Trono; Addgene plasmid # 12260) and 4.8 &#x003BC;g <italic>pVSVG</italic> (ViraPower&#x02122; Lentiviral Packaging Mix, Invitrogen, New Zealand) in Opti-MEM (Life Technologies, New Zealand) containing Lipofectamine-2000 (Life Technologies, New Zealand). The virus-containing media was recovered 48 h post-transfection. Viral particles were concentrated by ultra-centrifugation in a Beckman L-70 (SW28 rotor; Beckman Coulter, Carlsbad, CA, USA) at 110,000 &#x000D7; <italic>g</italic> for 90 min at 4&#x000B0;C and the viral pellet was resuspended in lactose (40 mg/mL in Dulbecco&#x02019;s phosphate buffered saline) and stored at &#x02212;80&#x000B0;C (Schoderboeck et al., <xref ref-type="bibr" rid="B53">2015</xref>). The viral genomic titres were determined using qPCR with primers for an enhancer incorporated into the lentiviral vectors; woodchuck posttranscriptional response element (Supplementary Table S1), as previously described in Best et al. (<xref ref-type="bibr" rid="B6">2017</xref>). The titres ranged from 7.02 &#x000D7; 10<sup>9</sup> &#x02212; 3.72 &#x000D7; 10<sup>10</sup> genomes/mL.</p>
</sec>
<sec id="s2-3">
<title>Stereotaxic Surgeries for the Injection of Lentivirus</title>
<p>Male mice (P21&#x02013;25) were anesthetized by a sub-cutaneous injection of 0.05 mg/kg atropine (Baxter Healthcare Ltd.), 0.5 mg/kg domitor (Novartis New Zealand Ltd.) and 70 mg/kg ketamine (Parnell Laboratories New Zealand Ltd.) and secured onto stereotaxic equipment using 45&#x000B0; non-rupture ear bars and a inserting nose clamp gently into the mouth (310037R, Kopf Instruments). A 10 &#x003BC;L Nanofil syringe and 33 G needle assembly (World Precision Instruments, Sarasota, FL, USA) was used to deliver 1 &#x003BC;L of LV through a craniotomy in the skull at two injection sites in the M1; 0.85 mm anterior from Bregma, 1.65 mm lateral from midline and 0.85 mm depth from the pial layer and 0.4 mm anterior from Bregma, 1.4 mm lateral from the midline and 0.6 mm depth from the pial layer.</p>
</sec>
<sec id="s2-4">
<title>Histology</title>
<p>Four weeks after lentiviral injections, mice (P49&#x02013;53) were anesthetized with pentobarbitol (150 mg/kg) and perfused intracardially with 20 mL ice cold 0.9% (w/v) NaCl followed by 20 mL ice cold 4% (w/v) paraformaldehyde in 0.1 M phosphate buffer (pH 7.2). The brain was post-fixed overnight in 4% (w/v) PFA at 4&#x000B0;C, before cryoprotecting in 30% (w/v) sucrose for 2&#x02013;3 days at 4&#x000B0;C. Tissue was frozen in optimal cutting temperature medium (OCT), Tissue-Tek<sup>&#x000AE;</sup> (Thermo Fisher Scientific, New Zealand) before cutting. Coronal sections 40 &#x003BC;m thick were cut at &#x02212;20&#x000B0;C using a Leica CM3050 cryostat (Leica Biosystems, Lincolnshire, IL, USA). The sections were processed for immunohistochemistry (see Supplementary Methods) to enhance the GFP signal from <italic>Fezf2-Gfp</italic> mouse tissue and the LV reporter gene, mCherry.</p>
</sec>
<sec id="s2-5">
<title>Analysis of Transduction Efficiency <italic>In Vivo</italic></title>
<p>For transduction efficiency analysis of <italic>Fezf2</italic>-GFP positive cells <italic>in vivo</italic>, three <italic>Fezf2-Gfp</italic> male mice were injected with <italic>pLenti.SynI.mCherry.non-silencingshRNA</italic> and analyzed 4 weeks later. GFP and mCherry images were overlaid and ImageJ cell counter extension used to count the total number of GFP-positive cells in a section and GFP/mCherry-positive cells. Transduction efficiency of GFP-positive cells was calculated as: (total number of GFP cells co-expressing mCherry/total number of GFP cells) &#x000D7; 100. Mean transduction efficiency was determined from five to six sections per animal. The final mean was calculated across the three biological replicates and presented with the standard error of the mean.</p>
</sec>
<sec id="s2-6">
<title>Dissection of M1 for RNA Extraction</title>
<p>Four weeks after surgery the lentiviral injected mice (P49&#x02013;53) were anesthetized with pentobarbitol (150 mg/kg) and perfused intracardially with ice cold 0.9% (w/v) NaCl. One-millimetre coronal sections of the adult mouse brain were then made from Bregma 1.2&#x02013;0 using a Ted Pella acrylic mold (Ted Pella Inc., Redding, CA, USA). Brain slices were transferred to L15 complete media containing phenol red free Leibovitz&#x02019;s L15, 6% D-(+)-glucose (Sigma Aldrich, New Zealand) and 500 units penicillin/500 &#x003BC;g streptomyocin per mL (Invitrogen, New Zealand). A scalpel blade was used to dissect M1, including all layers and meninges, from coronal sections and an Olympus SZX12 with a Stereo Microscope Fluorescence Adapter with a 510&#x02013;540 nm excitation lamp and 600 nm longpass emission filter (Nightsea, Lexington, MA, USA) used for the detection of mCherry-positive tissue. The dissected tissue was immediately flash frozen in liquid nitrogen.</p>
</sec>
<sec id="s2-7">
<title>Preparation of RNA Samples from Mouse M1 Tissue for Transcriptomic Analysis</title>
<p>Frozen tissue was homogenized in 1 mL TRI<sup>&#x000AE;</sup> reagent (Sigma-Aldrich, New Zealand) using an RNase free plastic pestle. Tissue debris was removed by centrifugation before adding chloroform (0.2 mL) to the supernatant and mixing vigorously for 15 s. After a 2&#x02013;3 min incubation at room temperature, samples were centrifuged (12,000 &#x000D7; <italic>g</italic>) for 15 min at 4&#x000B0;C and the top aqueous phase removed to a fresh 1.5 mL eppendorf. This sample was then used as input to the Purelink<sup>&#x000AE;</sup> RNA extraction kit (Life Technologies, New Zealand) and RNA eluted in 30 &#x003BC;L of RNase/DNase free H<sub>2</sub>O.</p>
<p>Before library generation for RNA-seq, the RNA was further purified using the RNA clean and concentrator&#x02122;-5 (Zymo Research, Irvine, CA, USA). RNA quality was assessed using an Agilent Bioanalyzer&#x02122; and all samples had RIN numbers of 8.1 or higher. Libraries were prepared and sequenced from RNA samples by the Otago Genomics and Bioinformatics Facility. A TruSeq Stranded Total RNA Library Prep Kit (Illumina) was used and paired-end RNA-sequencing was performed on a HiSeq 2500 Illumina platform.</p>
</sec>
<sec id="s2-8">
<title>Bioinformatics</title>
<p>Read quality was assessed using FastQC (Babraham Institute) and reads were trimmed of universal Illumina adapter sequence using fastq-mcf (Aronesty, <xref ref-type="bibr" rid="B5">2011</xref>). Reads were mapped to the mouse genome build mm10 using tophat2 (Kim et al., <xref ref-type="bibr" rid="B29">2013</xref>) and SAMTools (Li et al., <xref ref-type="bibr" rid="B31">2009</xref>) was used to sort and index the resulting alignment bam files (mapped reads). Ensembl gene annotations were downloaded from the University of California Santa Cruz (UCSC) genome browser (January 2016) in BED format and read counts were assigned using BEDTools multiCov (Quinlan and Hall, <xref ref-type="bibr" rid="B48">2010</xref>).</p>
<p>Differential expression analysis was performed using DESeq2 (version 1.10.1; Love et al., <xref ref-type="bibr" rid="B36">2014</xref>) in R studio (R version 3.2.5; RStudio Team, <xref ref-type="bibr" rid="B51">2015</xref>). First, genes with low coverage were filtered out using the cpm function of the edgeR package (Robinson et al., <xref ref-type="bibr" rid="B49">2010</xref>). Only genes with &#x0003E;8 cpm in at least four samples were included in downstream differential expression analysis. Differentially expressed genes were selected with a false discovery rate (FDR) cutoff &#x02264;0.05 and log fold change (LFC) cutoff &#x02265;&#x000B1; 0.2.</p>
<p>Count data was transformed using the variance stabilizing transformation function in DESeq2 before clustering analysis. Unsupervised hierarchical clustering analysis was performed using R (version 3.2.5); first the top 8% most variable genes were identified across all eight samples, irrespective of treatment and a Euclidean distance matrix was produced using R package&#x02014;Another Multidimensional Analysis Package (Lucas, <xref ref-type="bibr" rid="B37">2009</xref>). The matrix was used as the input for unsupervised hierarchical clustering, which clusters samples according to the level of similarity identified by the distance matrix.</p>
<p>For heatmap generation the normalized counts were transformed using the DESeq2 variance stabilizing transformation and the z-score calculated for each sample. The heatmap was then generated using the heatmap.2 function in R&#x02019;s (version 3.2.3) gplots package. The MA plot was created in R Studio (R version 3.2.3) by plotting the log10 normalized base mean output from DESeq2 against the LFC.</p>
<p>To represent the differentially repressed and activated genes in development (Lodato et al., <xref ref-type="bibr" rid="B35">2014</xref>) and mature brain (our data), we used Network Analyst (Xia et al., <xref ref-type="bibr" rid="B64">2015</xref>) to generate a chord diagram.</p>
</sec>
<sec id="s2-9">
<title>Gene Ontology Analysis</title>
<p>Gene ontology and functional clustering analysis of all differentially expressed genes in mature M1 was performed using the online Database for Annotation, Visualization and Integrated Discovery (DAVID v6.7) tool: functional annotation (Huang et al., <xref ref-type="bibr" rid="B25">2007</xref>). Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis, gene ontology analysis of mature-specific and development-specific (Lodato et al., <xref ref-type="bibr" rid="B35">2014</xref>) <italic>Fezf2</italic>-regulated genes and mammalian phenotype analysis was performed using WebGestalt (Wang et al., <xref ref-type="bibr" rid="B62">2013</xref>). The details can be found in the Supplementary Methods.</p>
</sec>
<sec id="s2-10">
<title>Reverse Transcription and Quantitative PCR</title>
<p>RNA was treated with DNase I prior to cDNA synthesis. Five-hundred nanograms of RNA was added to 1 &#x000D7; DNase I buffer and 2 U of DNase I (Quantabio, Beverly, MA, USA) in a 10 &#x003BC;L reaction. After gentle mixing the reaction was incubated at 37&#x000B0;C for 30 min. One microliter of 10&#x000D7; stop buffer was added and incubated at 65&#x000B0;C for 10 min to inhibit DNase I activity. For cDNA synthesis, 60 &#x003BC;M of random hexamer primers were added to the DNase I treated RNA and incubated at 65&#x000B0;C for 10 min. A reaction mix was prepared with 200 nM dNTPs, 1&#x000D7; reaction buffer and 20 U RNase inhibitor (Roche, New Zealand) and added to each sample. Reverse transcriptase (RT; Roche, New Zealand) was then added (22 U) to each sample with the exception of the &#x02013;RT negative control. Samples were then incubated at 55&#x000B0;C for 30 min then 85&#x000B0;C for 5 min before cooling samples to 4&#x000B0;C. The resulting cDNA was stored at &#x02212;20&#x000B0;C.</p>
<p>Quantitative PCR was performed using a Roche LightCycler<sup>&#x000AE;</sup> 480 SYBR green system. For relative quantification, target genes were amplified from cDNA samples alongside three stable reference genes pre-validated using refFinder (Xie et al., <xref ref-type="bibr" rid="B65">2012</xref>). All primers were designed to span an exon-exon boundary using Primer-BLAST (Ye et al., <xref ref-type="bibr" rid="B67">2012</xref>; Supplementary Table S1). Each reaction contained 3 &#x003BC;L of cDNA (diluted 1:9 in RNase/DNase free H<sub>2</sub>O), 500 nM of each forward and reverse primer and 1 &#x000D7; LightCycler 480 SYBR Green I master mix (Roche, New Zealand) made to 10 &#x003BC;L with RNase/DNase free H<sub>2</sub>O. Reactions were loaded in triplicate in a LightCycler<sup>&#x000AE;</sup> 480 Multiwell &#x02212;96 or &#x02212;384 plate (Roche, New Zealand). A no template H<sub>2</sub>O and &#x02013;RT negative control reaction was included on each plate for each primer set. The amplification protocol included enzyme activation 95&#x000B0;C for 5 min followed by 50 cycles of 95&#x000B0;C (5 s), 60&#x000B0;C (5 s), 72&#x000B0;C (10 s). Primer efficiencies (Supplementary Table S1) were determined from a standard curve of known cDNA input using the LightCycler<sup>&#x000AE;</sup> 480 software.</p>
<p>Before relative quantification, standard deviation (SD) was calculated for all triplicates and when a single outlier was &#x0003E;2 SD from the mean it was removed. Mean Cp values were then used for relative quantification using the Pfaffl&#x02019;s (<xref ref-type="bibr" rid="B47">2001</xref>) method, with the ratio of the target gene expressed relative to the geomean of all reference genes.</p>
</sec>
<sec id="s2-11">
<title>Statistics</title>
<p>All statistical tests were performed using Prism 6 (Graphpad Software Inc., La Jolla, CA, USA). Unless stated otherwise, a two-tailed <italic>t</italic>-test was used for statistical analysis of mouse qPCR data. In the case of uneven variance a Mann-Whitney U test was applied. For all statistical analysis in the body of text the average is shown with standard error of the mean.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec id="s3-1">
<title>Lentiviral-Mediated Delivery of shRNA Constructs to the Mouse Primary Motor Cortex (M1)</title>
<p>We recently identified <italic>Fezf2</italic> expression in diverse pyramidal neuronal subtypes in layer 5 of the mature M1, including PT-PNs and IT-PNs (Tantirigama et al., <xref ref-type="bibr" rid="B59">2016</xref>). We therefore wanted to reduce <italic>Fezf2</italic> expression globally within the mature M1, in order to target all <italic>Fezf2</italic>-expressing neurons (Figure <xref ref-type="fig" rid="F1">1A</xref>). As FEZF2 plays an essential role in the developing forebrain (Molyneaux et al., <xref ref-type="bibr" rid="B40">2005</xref>; Hirata et al., <xref ref-type="bibr" rid="B23">2006</xref>; Srinivasan et al., <xref ref-type="bibr" rid="B58">2012</xref>), it was necessary to conditionally disrupt expression in the mature brain. To spatially and temporally restrict <italic>Fezf2</italic> knockdown to mature neurons of M1, we used lentiviral mediated-delivery of a <italic>mCherry-Fezf2 shRNA</italic> or a control <italic>mCherry-non-silencing shRNA</italic> construct under the regulation of the <italic>Synapsin I</italic> promoter (<italic>LV.SynI.mCherry.shRNA</italic>; Figures <xref ref-type="fig" rid="F1">1A,B</xref>). The spread of the virus and targeting of <italic>Fezf2</italic>-expressing neurons <italic>in vivo</italic> was first tested with the injection of <italic>LV.Syn.mCherry.non-silencingshRNA</italic> in three transgenic <italic>Fezf2-Gfp</italic> males. Brain sections were analyzed 4-weeks post-injection and the expression of mCherry was observed 1 mm (&#x000B1; 0.13, <italic>n</italic> = 3) rostral-caudal, inclusive of the two injection sites (Figure <xref ref-type="fig" rid="F1">1C</xref>). Of the <italic>Fezf2</italic>-GFP positive cells, 63% (&#x000B1; 1.65, <italic>n</italic> = 3) were transduced (mCherry-positive).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p>Lentiviral-mediated knockdown of <italic>Forebrain embryonic zinc finger 2</italic> (<italic>Fezf2</italic>) in the mature motor cortex. <bold>(A)</bold> Male mice aged P21&#x02013;25 were injected into the primary motor cortex (M1) with lentivirus (LV) expressing a mCherry reporter gene and either a <italic>Fezf2 shRNA</italic> or <italic>non-silencing shRNA</italic>. Four weeks post-injection M1 tissue was isolated according to mCherry expression and processed for RNA-seq analysis. <bold>(B)</bold> Schematic indicating the binding site for the <italic>Fezf2 shRNA</italic> in the <italic>Fezf2 mRNA</italic>. <bold>(C)</bold> Injection of <italic>LV.Syn.mCherry.non-silencingshRNA</italic> in M1 of <italic>Fezf2-Gfp</italic> mice validated the successful transduction of <italic>Fezf2</italic>-expressing neurons. Brain section is from Bregma +0.4. Scale bar is 500 &#x003BC;m or 50 &#x003BC;m (higher magnification images). <bold>(D)</bold> Quantitative PCR analysis was used to test the <italic>shRNA-</italic>mediated knockdown of <italic>Fezf2</italic> expression in the mature M1 of wildtype male mice (<italic>n</italic> = 4, 4; *<italic>p</italic> &#x0003C; 0.05, unpaired one-tailed <italic>t</italic>-test). <bold>(E)</bold> Stable HT1080 cells transduced with a green fluorescence protein (GFP)-mFEZF2 fusion construct were induced to express either the <italic>Fezf2 shRNA</italic> or <italic>non-silencing shRNA</italic> (control). Images indicate <italic>shRNA</italic> expression according the RFP reporter and GFP-mFEZF2 expression (GFP) at 0 h and 72 h after the induction of shRNA expression. Scale bar is 100 &#x003BC;m.</p></caption>
<graphic xlink:href="fnmol-10-00283-g0001.tif"/>
</fig>
<p>When injecting the <italic>Fezf2 shRNA</italic> into the M1 of <italic>Fezf2-Gfp</italic> mice, no changes in <italic>Fezf2</italic> expression were observed (data not shown). We previously demonstrated an increase in <italic>Fezf2 CDS</italic> expression in the <italic>Fezf2-Gfp</italic> mouse model (Tantirigama et al., <xref ref-type="bibr" rid="B59">2016</xref>), which could have affected the shRNA efficiency. Therefore we chose to complete <italic>Fezf2</italic> knockdown experiments in wildtype mice. Male Swiss Webster mice (P21&#x02013;25) were injected in M1 with either <italic>LV.Syn.mCherry</italic>.<italic>Fezf2shRNA</italic> LV or <italic>LV.Syn.mCherry</italic>.<italic>non-silencingshRNA</italic> (<italic>n</italic> = 4 of each; Figure <xref ref-type="fig" rid="F1">1A</xref>). At 4 weeks post-injection, <italic>Fezf2</italic>-expression was significantly decreased by 27% from 0.75 &#x000B1; 0.09 (<italic>n</italic> = 4) in the <italic>non-silencing shRNA-</italic>treated control M1 samples to 0.55 &#x000B1; 0.02 (<italic>n</italic> = 4) in the <italic>Fezf2 shRNA</italic>-treated samples (<italic>p</italic> = 0.03, one-tailed <italic>t-test</italic>; Figure <xref ref-type="fig" rid="F1">1D</xref>).</p>
<p>The lack of a good FEZF2 antibody prevented direct analysis of decreased protein expression in the M1 tissue. We therefore transduced a GFP-mFEZF2 fusion protein into HT1080 cells to monitor the efficacy of the <italic>Fezf2 shRNA</italic> on reducing protein levels. Qualitative analysis demonstrates a clear reduction in GFP expression at 72 h after the induction of <italic>Fezf2 shRNA</italic> expression in cells, whilst no reduction was observed in cells expressing the control <italic>non-silencing shRNA</italic> (Figure <xref ref-type="fig" rid="F1">1E</xref>). Additionally, the induction of <italic>Fezf2 shRNA</italic> expression before transduction of GFP-mFEZF2 maintains reduced GFP levels between 24 h and 72 h of expression (Supplementary Figure S1).</p>
<p>To control for potential off-target effects, the shRNA was checked for specificity. The <italic>Fezf2 shRNA</italic> showed 100% homology match to mouse <italic>Fezf2</italic> using basic local alignment search tool nucleotide (BLASTN, Altschul et al., <xref ref-type="bibr" rid="B3">1997</xref>). There was additional alignment to mouse <italic>Zfp523</italic> with a much lower query cover of 73% (Supplementary Table S2). It is considered that any sequence &#x02265;16 nt match (84%) to an off-target sequence would need to be discarded (Moore et al., <xref ref-type="bibr" rid="B42">2010</xref>). As this non-specific alignment has a lower percentage of query cover the shRNA is unlikely to be able to bind to and produce mRNA cleavage.</p>
</sec>
<sec id="s3-2">
<title>RNA-Sequencing of <italic>Fezf2 shRNA</italic>-Treated M1 Tissue Reveal Significant Changes in the Transcriptome Profiles</title>
<p>As <italic>Fezf2</italic> is a transcription factor, if it continues to have a role in mature tissue, we hypothesized that even a small change to <italic>Fezf2</italic> expression would result in changes to the gene expression profiles of <italic>Fezf2</italic>-reduced M1 tissue. In order to investigate this, we used RNA-seq to generate transcriptome profiles of the control and <italic>Fezf2 shRNA</italic>-treated M1 tissue (<italic>n</italic> = 4 of each). For each library &#x0007E;55 million total reads were generated. Concordant pair mapping rates to the mouse genome (mm10) were &#x0003E;89% (Table <xref ref-type="table" rid="T1">1</xref>), with &#x0003C;8% showing &#x0003E;20 multiple alignments. To ascertain whether <italic>Fezf2</italic> knockdown could lead to reproducible changes in the M1 transcriptome, we then performed unsupervised hierarchical clustering analysis on the most variably expressed genes across all <italic>Fezf2 shRNA</italic>-treated and <italic>non-silencing shRNA</italic> treated M1 samples, irrespective of their treatment. Accordingly, two main sample clusters were identified, separating samples into knockdown and control groups (Figure <xref ref-type="fig" rid="F2">2A</xref>).</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption><p>Mapping rate of reads generated from RNA-sequencing of <italic>Fezf2 shRNA</italic> (<italic>Fezf2</italic> KD) or <italic>non-silencing shRNA</italic> (control) treated tissue.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th/>
<th align="center">Number of paired raw reads</th>
<th align="center">Number of paired reads after QC</th>
<th align="center">% paired reads after QC</th>
<th align="center">Number of aligned paired reads</th>
<th align="center">% concordant pair alignment</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">Control 1</td>
<td align="center">27709366</td>
<td align="center">27709255</td>
<td align="center">99.99</td>
<td align="center">25261582</td>
<td align="center">90.4</td>
</tr>
<tr>
<td align="left">Control 2</td>
<td align="center">26807763</td>
<td align="center">26807639</td>
<td align="center">99.99</td>
<td align="center">24370739</td>
<td align="center">90.5</td>
</tr>
<tr>
<td align="left">Control 3</td>
<td align="center">27120622</td>
<td align="center">27120483</td>
<td align="center">99.99</td>
<td align="center">24368801</td>
<td align="center">89.1</td>
</tr>
<tr>
<td align="left">Control 4</td>
<td align="center">26665873</td>
<td align="center">26665772</td>
<td align="center">99.99</td>
<td align="center">24233182</td>
<td align="center">90</td>
</tr>
<tr>
<td align="left"><italic>Fezf2</italic> KD 1</td>
<td align="center">28175979</td>
<td align="center">28175862</td>
<td align="center">99.99</td>
<td align="center">25454116</td>
<td align="center">89.5</td>
</tr>
<tr>
<td align="left"><italic>Fezf2</italic> KD 2</td>
<td align="center">27872058</td>
<td align="center">27871935</td>
<td align="center">99.99</td>
<td align="center">25199887</td>
<td align="center">89.9</td>
</tr>
<tr>
<td align="left"><italic>Fezf2</italic> KD 3</td>
<td align="center">27738010</td>
<td align="center">27737896</td>
<td align="center">99.99</td>
<td align="center">24973199</td>
<td align="center">89.6</td>
</tr>
<tr>
<td align="left"><italic>Fezf2</italic> KD 4</td>
<td align="center">27358847</td>
<td align="center">27358749</td>
<td align="center">99.99</td>
<td align="center">24522056</td>
<td align="center">88.9</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p>Conditional knockdown of <italic>Fezf2</italic> leads to significant changes in the transcriptome profile of M1. <bold>(A)</bold> Unsupervised hierarchical clustering of the top 8% most variable genes separated the control (<italic>non-silencing shRNA</italic>; circle) and <italic>Fezf2-shRNA</italic> treated (square) M1 tissue samples. <bold>(B)</bold> Heatmap shows the z-score from the transformed counts of each individual sample replicate, for all differentially expressed genes (false discovery rate (FDR) &#x02264; 0.05; log fold change (LFC) &#x02265; &#x000B1; 0.2) identified in <italic>Fezf2</italic>-reduced M1. <bold>(C)</bold> MA plot shows (log10) normalized mean of all genes expressed across the M1 samples, plotted against the LFC. Upregulated genes (FDR &#x02264; 0.05; LFC &#x02265; 0.2) are in red and downregulated genes (FDR &#x02264; 0.05; LFC &#x02265; &#x02212;0.2) are in blue.</p></caption>
<graphic xlink:href="fnmol-10-00283-g0002.tif"/>
</fig>
<p>Having identified a clear separation in the transcriptome profiles of control (<italic>non-silencing shRNA</italic>-treated) and <italic>Fezf2 shRNA</italic>-treated M1 tissues, we next wanted to determine which gene changes underpinned the sample clustering. We performed DESeq2 differential expression analyses on the M1 transcriptomes and revealed 756 genes to have significantly changed gene expression with the knockdown of <italic>Fezf2</italic> (FDR &#x02264; 0.05, LFC &#x02265; &#x000B1; 0.2; Figure <xref ref-type="fig" rid="F2">2B</xref> heatmap; Supplementary Table S3), suggesting a regulatory role for <italic>Fezf2</italic> in the mature M1. The MA plot shown in Figure <xref ref-type="fig" rid="F2">2C</xref> highlights the genes significantly up- and down-regulated with <italic>Fezf2</italic> knockdown (FDR &#x02264; 0.05, LFC &#x02265; &#x000B1; 0.2). For technical validation of RNA-seq, qPCR was used to analyze two randomly selected significantly changed genes, <italic>Nrxn1</italic> (<italic>p</italic> = 0.0013) and <italic>Grin2a</italic> (<italic>p</italic> = 0.0571; Figure <xref ref-type="fig" rid="F3">3A</xref>), and one gene that did not show significant differential expression, <italic>Clint1</italic> (<italic>p</italic> = 0.38). The LFC values obtained from the qPCR data of these three genes and <italic>Fezf2</italic> together displayed a significant positive correlation with the LFCs identified from RNA-seq analysis (<italic>R</italic><sup>2</sup> = 0.97, <italic>p</italic> &#x0003C; 0.05; Figure <xref ref-type="fig" rid="F3">3B</xref>), demonstrating technical validation of the RNA-seq platform.</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption><p>Quantitative PCR validation of RNA-seq data. <bold>(A)</bold> Two genes, <italic>Grin2a</italic> and <italic>Nrxn1</italic>, that were significantly changed between the <italic>Fezf2 shRNA</italic> and <italic>non-silencing shRNA</italic> treated M1 tissue, were validated using qPCR (<italic>n</italic> = 4, 4; **<italic>p</italic> &#x0003C; 0.01, unpaired two-tailed <italic>t</italic>-test; <sup>#</sup><italic>p</italic> &#x0003C; 0.1, Mann-Whitney U test). <bold>(B)</bold> Pearson&#x02019;s correlation analysis was used to determine the correlation between the LFC values of genes validated by qPCR and those identified by RNA-seq (<italic>R</italic><sup>2</sup> = 0.97; <italic>p</italic> &#x0003C; 0.05).</p></caption>
<graphic xlink:href="fnmol-10-00283-g0003.tif"/>
</fig>
<p>To further corroborate that the observed changes in gene expression were caused by the reduction of <italic>Fezf2</italic>, we compared our <italic>Fezf2</italic>-regulated gene list to previously identified direct targets of FEZF2 (Chromatin immunoprecipitation sequencing data; Lodato et al., <xref ref-type="bibr" rid="B35">2014</xref>). Comparisons revealed 65% of the significantly changed genes in mature M1 (FDR &#x02264; 0.05, LFC &#x02265; &#x000B1; 0.2) are direct targets of FEZF2 (Supplementary Table S4), this percentage was similar amongst the <italic>Fezf2</italic>-regulated genes identified in development (67%; Lodato et al., <xref ref-type="bibr" rid="B35">2014</xref>). Amongst the differentially expressed genes there were known developmental targets of FEZF2, including <italic>Satb2</italic> (LFC = 0.26, FDR = 0.02; Figure <xref ref-type="fig" rid="F2">2B</xref>) and <italic>Auts2</italic> (LFC = 0.45, FDR = 0.001; (Srinivasan et al., <xref ref-type="bibr" rid="B58">2012</xref>); Figure <xref ref-type="fig" rid="F2">2B</xref>). With a number of the deregulated genes in the <italic>Fezf2-shRNA</italic> treated M1 not known to be direct targets, and several such as <italic>Satb2</italic> and <italic>Auts2</italic>, being transcription factors themselves, it is likely that many of the genes in this dataset could be indirectly affected by the knockdown of <italic>Fezf2</italic> expression.</p>
</sec>
<sec id="s3-3">
<title>Comparison of <italic>Fezf2</italic>-Regulated Genes Identified in Developing and Mature Cortical Tissues Reveal a Change in Function</title>
<p>Intriguingly, of the significantly changed genes only 98 had decreased expression (13% of all genes), whilst 658 displayed an increase in expression (87%) after <italic>Fezf2</italic> knockdown (Figure <xref ref-type="fig" rid="F4">4A</xref>). These results indicate that <italic>Fezf2</italic> acts predominantly as a transcriptional repressor in the mature M1, whether directly or indirectly. Conversely, microarray analysis of <italic>Fezf2</italic> overexpression in the developing cortex indicated a prominent activator role for <italic>Fezf2</italic> (79% induced by Fezf2; Lodato et al., <xref ref-type="bibr" rid="B35">2014</xref>). We were therefore interested in comparing our dataset of <italic>Fezf2</italic>-regulated genes (488 genes) to those identified previously in developing cortical neurons (496 genes; Lodato et al., <xref ref-type="bibr" rid="B35">2014</xref>), focusing specifically on the known direct targets of FEZF2. Our comparison revealed an overlap of only 42 genes between these two datasets (Figure <xref ref-type="fig" rid="F4">4B</xref>; Supplementary Table S5). All genes activated by <italic>Fezf2</italic> in development were repressed in mature tissue (Figure <xref ref-type="fig" rid="F4">4B</xref>) and of the genes repressed by <italic>Fezf2</italic> in development only one became a target of transcriptional activation in mature tissue (<italic>Gas5</italic>; Figure <xref ref-type="fig" rid="F4">4B</xref>). The small overlap in <italic>Fezf2</italic>-regulated genes between developing and mature settings indicates a distinct change in role for FEZF2, which is further supported by the predominant switch in role from activator to repressor.</p>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption><p>Changes in <italic>Fezf2</italic>-regulated genes between the developing and mature cortex indicate a switch in function for <italic>Fezf2</italic>. <bold>(A)</bold> Analysis of the differentially expressed gene list revealed that most were significantly upregulated (green) after <italic>Fezf2</italic> knockdown. <bold>(B)</bold> Chord diagram shows <italic>Fezf2</italic>-regulated genes common to both developing (Lodato et al., <xref ref-type="bibr" rid="B35">2014</xref>) and mature tissues. Each line represents a gene and connects the groups in which the gene is present (mature repressed, blue; mature activated, orange; development repressed, purple and development activated, red). <bold>(C)</bold> Venn diagram shows <italic>Fezf2</italic>-regulated genes in mature and developing tissue that are known direct targets of FEZF2 (Lodato et al., <xref ref-type="bibr" rid="B35">2014</xref>). To look for differences in the temporal specific <italic>Fezf2</italic>-regulated genes, gene ontology analysis using WebGestalt was performed on the two groups individually. The number of genes associated with the top 10 significantly enriched GO terms are plotted for mature- (blue) and development-specific (red) genes.</p></caption>
<graphic xlink:href="fnmol-10-00283-g0004.tif"/>
</fig>
<p>As there was only a small overlap in the <italic>Fezf2</italic>-regulated genes, we were interested to investigate whether the uniquely expressed genes indicate a change in function, specific to developing or mature neurons. To do this, we performed GO analysis on the <italic>Fezf2</italic>-regulated genes changed only in development or mature tissue. The top 10 significant biological processes enriched in the development-specific genes indicated a function in nervous system development, including neuron projection development (Figure <xref ref-type="fig" rid="F4">4C</xref>; Supplementary Table S6). This was corroborated by the cellular component (CC) terms, which were significantly enriched for localization to neuron or cell projection part, suggesting an importance for axonal targeting (Figure <xref ref-type="fig" rid="F4">4C</xref>; Supplementary Table S6). Analysis of the top enriched molecular function (MF) terms revealed an enriched role for <italic>Fezf2</italic>-regulated genes in transcription factor activity (Figure <xref ref-type="fig" rid="F4">4C</xref>; Supplementary Table S6), including factors such as <italic>Ctip2</italic> (<italic>Bcl11b</italic>) that are important for the specification of layer-restricted PN types. This highlights FEZF2&#x02019;s known key role in the regulatory genetic networks, which direct the correct development of the layered cortex (Srinivasan et al., <xref ref-type="bibr" rid="B58">2012</xref>).</p>
<p>Comparative analysis of the mature M1-specific genes revealed some overlap in the biological process terms of the development-specific genes (e.g., neuron differentiation, neurogenesis), however unique terms identified in this dataset included receptor signaling pathways (Figure <xref ref-type="fig" rid="F4">4C</xref>; Supplementary Table S6). Accordingly, analysis of the CC terms amongst the mature-specific genes revealed enrichment of localization to the synaptic and postsynaptic membranes as well as ion channel complexes (Figure <xref ref-type="fig" rid="F4">4C</xref>; Supplementary Table S6). Moreover, analysis of MF terms indicated a unique enrichment of roles in the regulation of ion channel activity amongst the mature-specific genes (Figure <xref ref-type="fig" rid="F4">4C</xref>; Supplementary Table S6). This term enrichment analysis indicates an important functional role for the <italic>Fezf2</italic>-regulated mature-specific genes in the transmission of signals and movement of ions, important functions for mature neuron activity.</p>
<p>Together these gene ontology analyses indicate a distinct role for unique <italic>Fezf2</italic>-regulated genes in the developing and mature cortex, relevant to the environmental setting. This could suggest that the divergence in <italic>Fezf2&#x02019;s</italic> role is influenced by additional genetic or epigenetic factors that change between development and maturity.</p>
</sec>
<sec id="s3-4">
<title>KEGG Pathway Analysis of <italic>Fezf2</italic>-Regulated Genes</title>
<p>Having demonstrated significant molecular effects of reducing <italic>Fezf2</italic> in the mature M1, and a unique role for the direct FEZF2 targets in mature tissue, we were interested in investigating further the functional role for all <italic>Fezf2</italic>-regulated genes. We first used the KEGG pathway database to investigate whether the <italic>Fezf2</italic>-regulated genes were statistically enriched for specific biochemical pathways. Amongst the 756 differentially expressed genes there was significant enrichment of seven KEGG pathways (adjusted <italic>p</italic>-value &#x02264; 0.05; Figure <xref ref-type="fig" rid="F5">5A</xref>; Table <xref ref-type="table" rid="T2">2</xref>).</p>
<fig id="F5" position="float">
<label>Figure 5</label>
<caption><p>Functional annotation of significantly altered genes after <italic>Fezf2</italic> knockdown in mouse M1. <bold>(A)</bold> KEGG pathway analysis of <italic>Fezf2</italic>-regulated genes. Seven pathways were significantly enriched (&#x02212;log10 adjusted <italic>p</italic>-value &#x02265; 1.3). <bold>(B)</bold> Mean change in gene expression (&#x000B1;SEM) for pathway-associated (neuroactive ligand receptor interaction, calcium signaling pathway and cell adhesion molecules) genes differentially expressed in <italic>Fezf2</italic>-reduced M1. Relative expression is calculated as the transformed counts for each <italic>Fezf2</italic>-reduced M1 sample&#x02014;the mean transformed counts of the control samples. <bold>(C)</bold> Analysis of all the <italic>Fezf2</italic>-regulated genes using Database for Annotation, Visualization and Integrated Discovery (DAVID) revealed 15 clusters with significant enrichment (&#x02212;log10 <italic>p</italic>-value &#x02265; 1.3). Red dashed line indicates cut-off for significance. <bold>(D)</bold> Overrepresentation analysis of <italic>Fezf2</italic>-regulated genes using the mammalian phenotype ontology database. Of the top 10 significant phenotypes enriched four main groups were identified; learning, motor function, synaptic transmission and social behavior. Key indicates significance (adjusted <italic>p</italic>-value &#x02264; 0.05).</p></caption>
<graphic xlink:href="fnmol-10-00283-g0005.tif"/>
</fig>
<table-wrap id="T2" position="float">
<label>Table 2</label>
<caption><p>Results from Kyoto Encyclopedia Genes and Genomes (KEGG) pathway analysis of <italic>Fezf2</italic>-regulated genes.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left">KEGG ID</th>
<th align="left">Name</th>
<th align="center">FDR</th>
<th align="center">Number of genes</th>
<th align="left">Gene symbol</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">mmu04080</td>
<td align="left">Neuroactive ligand-receptor interaction</td>
<td align="center">5.62E-03</td>
<td align="center">18</td>
<td align="left"><italic>Grm3, Grm5, Grm7, Grik4, Chrna7, Gabra2, Gabrb1, Gabrb3, Gabrg3, Ghr, Gria4, Grik2, Grin2a, Grm1, Hrh2, Htr2c, Thrb, Chrm2</italic></td>
</tr>
<tr>
<td align="left">mmu04724</td>
<td align="left">Glutamatergic synapse</td>
<td align="center">3.58E-02</td>
<td align="center">16</td>
<td align="left"><italic>Grm3, Grm5, Grm7, Grik4, Cacna1c, Cacna1d, Gria4, Grik2, Grin2a, Grm1 Prkca, Plcb1, Adcy2, Shank2, Dlgap1, Homer2</italic></td>
</tr>
<tr>
<td align="left">mmu04020</td>
<td align="left">Calcium signaling pathway</td>
<td align="center">4.18E-02</td>
<td align="center">16</td>
<td align="left"><italic>Camk2d, Grm5, Chrna7, Cacna1b, Cacna1c, Cacna1d, Erbb4, Grin2a, Grm1, Hrh2, Htr2c, Prkca, Plcb1, Adcy2, Chrm2, Plcd3</italic></td>
</tr>
<tr>
<td align="left">mmu04725</td>
<td align="left">Cholinergic synapse</td>
<td align="center">4.18E-02</td>
<td align="center">14</td>
<td align="left"><italic>Camk2d, Kcnq3, Ache, Chrna7, Cacna1b, Cacna1c, Cacna1d, Fyn, Kcnq1, Prkca, Plcb1, Adcy2, Kcnq5, Chrm2</italic></td>
</tr>
<tr>
<td align="left">mmu04723</td>
<td align="left">Retrograde endocannabinoid signaling</td>
<td align="center">4.18E-02</td>
<td align="center">14</td>
<td align="left"><italic>Grm5, Cacna1b, Cacna1c, Cacna1d, Gabra2, Gabrb1, Gabrb3, Gabrg3, Gria4, Grm1, Prkca, Plcb1, Adcy2, Abhd6</italic></td>
</tr>
<tr>
<td align="left">mmu04514</td>
<td align="left">Cell adhesion molecules (CAMs)</td>
<td align="center">4.18E-02</td>
<td align="center">11</td>
<td align="left"><italic>Cdh4, H2-Q4, Ncam1, Ncam2, Nrxn1, Nrxn3, Nlgn1, Ptprm, Lrrc4c, Negr1, Nectin3</italic></td>
</tr>
<tr>
<td align="left">mmu05033</td>
<td align="left">Nicotine addiction</td>
<td align="center">4.18E-02</td>
<td align="center">8</td>
<td align="left"><italic>Chrna7, Cacna1b, Gabra2, Gabrb1, Gabrb3, Gabrg3, Gria4, Grin2a</italic></td>
</tr>
</tbody>
</table>
</table-wrap>
<p>The top significantly overrepresented pathway was neuroactive ligand-receptor interaction (Figure <xref ref-type="fig" rid="F5">5A</xref>; Table <xref ref-type="table" rid="T2">2</xref>). Similarly, there was significant enrichment of the glutamatergic synapse, cholinergic synapse, retrograde endocannabinoid signaling and nicotine addiction pathways (Figure <xref ref-type="fig" rid="F5">5A</xref>). Together, these pathways included genes important for neurotransmitter signaling, movement of ions at the membrane and synaptic scaffolding (Table <xref ref-type="table" rid="T2">2</xref>). The enrichment of this group of pathways provides evidence of a functional role for <italic>Fezf2</italic> in regulating neuronal signaling at the synapse.</p>
<p>In addition to the general role for <italic>Fezf2</italic>-regulated genes in neuronal transmission, two other pathways were significantly overrepresented in this gene set. Sixteen <italic>Fezf2</italic>-regulated genes were identified in the calcium-signaling pathway (Figure <xref ref-type="fig" rid="F5">5A</xref>; Table <xref ref-type="table" rid="T2">2</xref>), with the dysregulated genes predominantly involved in the calcium transport at the membrane (5/16 genes; <italic>Cacna1b, c, d</italic>, <italic>Grin2a</italic> and <italic>Chrna7</italic>) or triggering intracellular calcium release (9/16 genes; <italic>Grm1, Erbb4, Grm5, Htr2c, Prkca, Plcb1, Adcy2, Chrm2</italic> and <italic>Plcd3</italic>). The nature of the enriched genes in the calcium signaling pathway therefore suggests an importance for <italic>Fezf2</italic> in the regulation of calcium flux in neurons, which is important to the plasticity of neurons (Adasme et al., <xref ref-type="bibr" rid="B1">2011</xref>).</p>
<p>Finally, 11 genes were identified in the cell adhesion molecules pathway. Most cell adhesion molecules changed here after <italic>Fezf2</italic> knockdown are associated with synaptic interactions (7/11; <italic>Ncam1, Ncam2, Nrxn1, Nrxn3, Nlgn1, Negr1</italic> and <italic>Nectin3</italic>), providing further support to the role for <italic>Fezf2</italic> in the regulation of neuronal transmission. The remaining genes were implicated in either neuronal growth cone and axon association (<italic>Ptprm</italic> and <italic>Lrrc4c</italic>) or the immune system (<italic>H2-Q4</italic>; Table <xref ref-type="table" rid="T2">2</xref>).</p>
<p>Analysis of the gene expression changes in these pathways revealed nearly all but one of the <italic>Fezf2</italic>-regulated genes as up-regulated (Figure <xref ref-type="fig" rid="F5">5B</xref>). These analyses together indicate a negative regulatory role for <italic>Fezf2</italic> in neuronal signaling and plasticity in the mature M1.</p>
</sec>
<sec id="s3-5">
<title>Gene Ontology Analysis of <italic>Fezf2</italic>-Regulated Genes</title>
<p>To further investigate enrichment of functional roles for the <italic>Fezf2</italic>-regulated genes in mature M1, we performed functional annotation clustering based on gene ontology classes using DAVID (Huang et al., <xref ref-type="bibr" rid="B25">2007</xref>). Fifteen significantly overrepresented functional clusters were found (Figure <xref ref-type="fig" rid="F5">5C</xref>; Supplementary Table S7), which together additionally suggests a functional role for <italic>Fezf2</italic> in mediating neuronal transmission and function. For example, clusters included an enrichment of genes involved in synaptic transmission, regulation of ion channel activity and encoding mRNAs that localize to the synapse or axon part (Figure <xref ref-type="fig" rid="F5">5C</xref>).</p>
<p>In addition to the generalized functional role for <italic>Fezf2</italic> in neuronal activity, a significant functional cluster showed an enrichment of genes important for regulating behavior (locomotory, sensory perception and learning/memory; Figure <xref ref-type="fig" rid="F5">5C</xref>). To examine whether these behavior-related genes have a direct association with specific known phenotypes we performed overrepresentation analysis using the mammalian phenotype ontology database (Smith et al., <xref ref-type="bibr" rid="B55">2004</xref>). Amongst the top 10 significantly overrepresented phenotypes four main groups were identified, abnormal learning/memory, abnormal motor capabilities, abnormal social interaction and abnormal synaptic transmission (Figure <xref ref-type="fig" rid="F5">5D</xref>; Supplementary Table S8), similar to the findings from the DAVID analysis. However, the use of this database also identified significant overrepresentation of specific behavioral phenotypes associated with these main groups, including abnormal associative learning, hyperactivity and abnormal locomotor activation (Figure <xref ref-type="fig" rid="F5">5D</xref>; Supplementary Table S8). Based on these results maintaining <italic>Fezf2</italic> expression could therefore be functionally important to the normal regulation of behavior, particularly learning and motor behavior.</p>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>During development, <italic>Fezf2</italic> has a defined function regulating the expression of genes important to the correct specification of axonal projection and directing the excitatory fate of CSpPNs in layer 5 of the cortex (Chen B. et al., <xref ref-type="bibr" rid="B9">2005</xref>; Chen J.-G. et al., <xref ref-type="bibr" rid="B10">2005</xref>; Molyneaux et al., <xref ref-type="bibr" rid="B40">2005</xref>; Lodato et al., <xref ref-type="bibr" rid="B35">2014</xref>). Although there is significant understanding of the regulatory role FEZF2 plays in cortical development (Molyneaux et al., <xref ref-type="bibr" rid="B40">2005</xref>; Srinivasan et al., <xref ref-type="bibr" rid="B58">2012</xref>; Guo et al., <xref ref-type="bibr" rid="B20">2013</xref>), the impact of changing <italic>Fezf2</italic> gene expression levels in the mature brain has been largely neglected. In this study, we investigated the hypothesis that <italic>Fezf2</italic> expression in the mature M1 continues to have an important functional role for the regulation of gene expression. Here, our results demonstrate that reducing <italic>Fezf2</italic> expression, specifically in M1, causes significant changes to the transcriptome, altering the expression of genes that collectively have the potential to disrupt normal neuronal function and behavior.</p>
<p>Notably, our dataset reveals a predominant repressor role for <italic>Fezf2</italic> in mature M1 (Figure <xref ref-type="fig" rid="F4">4A</xref>), which is in contrast to the previously observed activator role for <italic>Fezf2</italic> in development (Lodato et al., <xref ref-type="bibr" rid="B35">2014</xref>). In accordance with our findings, <italic>FEZF2</italic> is a known tumor suppressor gene in mature tissue, with the silencing of <italic>FEZF2</italic> expression causative of nasopharyngeal carcinoma and implicated in brain tumors (Shu et al., <xref ref-type="bibr" rid="B54">2013</xref>). This contrast in regulatory function could indicate an important adaptive change for <italic>Fezf2</italic> based on tissue state. Certainly, our analyses of the <italic>Fezf2</italic>-regulated genes identified in developing and mature tissues revealed only a small subset common to both datasets and two distinct sets of genes that together have unique functional roles specific to each environmental setting (Figure <xref ref-type="fig" rid="F4">4C</xref>). Such a distinctive transition in <italic>Fezf2</italic> function could be indicative of an influence from changes in the chromatin landscape that are commonly observed through developing and differentiated cell states. For example, chromatin becomes more compact in differentiated cells (Chen and Dent, <xref ref-type="bibr" rid="B11">2014</xref>), which could refine the binding sites available to FEZF2. However, of the <italic>Fezf2</italic>-regulated genes common to developing and mature tissue, there was a shift of all genes once activated by <italic>Fezf2</italic> to be repressed (Figure <xref ref-type="fig" rid="F4">4B</xref>). FEZF2 itself could therefore be important for regulating changes to the chromatin state, to allow a switch in activation to repression of the same gene. Transcription factors, once bound to the DNA, can regulate active or repressive changes to chromatin remodeling, dependent on the factors recruited (Brettingham-Moore et al., <xref ref-type="bibr" rid="B7">2015</xref>). For example, transcription factor RUNX1, essential to hematopoietic differentiation, recruits protein arginine methyltransferase 6 (PRMT6) in progenitor cells, which mediates repressive epigenetic modifications to the genes required for differentiation. Once the progenitor cells differentiate, the association of RUNX1 with PRMT6 is lost and a coactivator complex recruited in its place (Herglotz et al., <xref ref-type="bibr" rid="B22">2013</xref>). <italic>Fezf2</italic> interacts with members of the corepressor groucho family (Zhang et al., <xref ref-type="bibr" rid="B69">2014</xref>), which can recruit additional factors such as PRMT5 to mediate repressive modifications to the chromatin (Patel et al., <xref ref-type="bibr" rid="B45">2012</xref>). Increased availability and/or increased interaction with such cofactors could facilitate the FEZF2 repressor function in mature tissues.</p>
<p>Changes in gene expression are commonly observed in neurological disease (Wang et al., <xref ref-type="bibr" rid="B63">2007</xref>; Satoh et al., <xref ref-type="bibr" rid="B52">2014</xref>) and may represent negative changes in neural cells. For example, disruption to the expression of genes that dictate neuronal identity could contribute to the progression of neuropsychiatric and neurodegenerative disease (Kadkhodaei et al., <xref ref-type="bibr" rid="B28">2009</xref>; Liu et al., <xref ref-type="bibr" rid="B33">2010</xref>; Song et al., <xref ref-type="bibr" rid="B56">2011</xref>; Deneris and Hobert, <xref ref-type="bibr" rid="B13">2014</xref>; Jaitner et al., <xref ref-type="bibr" rid="B27">2016</xref>). Our previous characterization of the functional phenotypes in <italic>Fezf2</italic>-expressing neurons of M1 identified a wider action potential in <italic>Fezf2</italic>-expressing neurons indicating an enhancement of calcium flux in these neurons (Tantirigama et al., <xref ref-type="bibr" rid="B60">2014</xref>, <xref ref-type="bibr" rid="B59">2016</xref>). It was therefore noteworthy to find an enrichment of <italic>Fezf2</italic>-regulated genes involved in the regulation of calcium flux (Figures <xref ref-type="fig" rid="F5">5A,B</xref>), a function directly relevant to <italic>Fezf2</italic>-expressing neuronal phenotypes. Nearly all the <italic>Fezf2</italic>-regulated genes identified in the calcium-signaling pathway here were upregulated with <italic>Fezf2</italic> knockdown, suggesting that <italic>Fezf2</italic> is a negative regulator of calcium flux. This negative regulation could have huge importance in maintaining healthy mature neurons, as excessive calcium signaling is a common trait in several neurodegenerative diseases, including ALS (Marambaud et al., <xref ref-type="bibr" rid="B38">2009</xref>). Additional enriched pathways and Gene Ontology analysis also indicated a general functional importance for <italic>Fezf2</italic>-regulated genes in neuronal signaling and plasticity (Figures <xref ref-type="fig" rid="F5">5A,C</xref>). The regulation of synaptic transmission and cell signaling is essential to the phenotype of neurons and would therefore indicate a role for <italic>Fezf2</italic> in sustaining neuronal phenotypes in the healthy mature M1. It will be interesting to investigate the effects of these gene changes on the functional phenotypes of <italic>Fezf2</italic>-expressing neurons in M1.</p>
<p>Gene Ontology and Phenotype Ontology analysis of <italic>Fezf2</italic>-regulated genes additionally indicated a functional role in regulating behavior (Figures <xref ref-type="fig" rid="F5">5C,D</xref>), with specific behavior phenotypes including abnormal associative learning, abnormal social interaction, abnormal locomotor activation and hyperactivity (Figure <xref ref-type="fig" rid="F5">5D</xref>). As our work is the first main study of <italic>Fezf2&#x02019;s</italic> role in the mature brain, there is currently no research investigating the effects of <italic>Fezf2</italic> disruption on adult behavior, though interestingly hyperactivity is a developmental behavioral phenotype observed in <italic>Fezf2&#x02212;/&#x02212;</italic> mice (Hirata et al., <xref ref-type="bibr" rid="B24">2004</xref>). Our findings of enriched associations in the mature M1 <italic>Fezf2</italic>-regulated genes to highly specific behavior phenotypes indicate that temporal disruption to <italic>Fezf2</italic> expression could negatively impact normal behavior.</p>
</sec>
<sec sec-type="conclusion" id="s5">
<title>Conclusion</title>
<p>Here we used lentiviral-mediated conditional knockdown and RNA-seq technologies to provide evidence of a regulatory role for <italic>Fezf2</italic> in the mature mammalian brain. Our findings strengthen the idea that active expression of transcription factors is critical for the genetic networks in a healthy adult brain. Through the comparison of genes regulated by <italic>Fezf2</italic> in developing and mature tissues we demonstrate dynamic changes in the functional role of <italic>Fezf2</italic>. Moreover, the overrepresentation analyses of pathway and phenotype datasets, for <italic>Fezf2</italic>-regulated genes in mature M1, emphasize the potential functional implications of disrupting these gene networks. Together this highlights an importance for identifying and understanding the role of regulatory factors in matured neuronal subtypes.</p>
</sec>
<sec id="s6">
<title>Accession Code</title>
<p>RNA-seq data, GSE102365.</p>
</sec>
<sec id="s7">
<title>Author Contributions</title>
<p>AJC, RME and SMH: study concept and design. AJC and HEW performed the experiments and acquired data. AJC, HEW, RME and SMH: analysis and interpretation of the data. AJC: drafting of the manuscript. AJC, SMH, RME and HEW: major critical revisions of the manuscript. All authors had full access to the manuscript and data for approval.</p>
</sec>
<sec id="s8">
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<ack>
<p>The authors thank Dr. Aaron Jeffs, Dr. Monika Zavodna and Les McNoe from the Otago Genomics and Bioinformatics Facility (OGBF) for preparing and sequencing the cDNA libraries and Dr. Elizabeth Permina (OGBF) for her assistance in establishing a pipeline for analysis of the RNA-seq data. The authors would also like to thank Professor Peter Dearden for his comments on the manuscript.</p>
</ack>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> This research was supported by Royal Society of New Zealand Marsden Fund, UOO0908; University of Otago Research Grant and University of Otago Dean&#x02019;s Bequest Fund (SMH and RME); University of Otago PhD scholarship to AJC.</p>
</fn>
</fn-group>
<sec sec-type="supplementary material" id="s9">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="http://journal.frontiersin.org/article/10.3389/fnmol.2017.00283/full#supplementary-material">http://journal.frontiersin.org/article/10.3389/fnmol.2017.00283/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Table_1.xlsx" id="SM1" mimetype="application/xlsx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table_2.xlsx" id="SM2" mimetype="application/xlsx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table_3.xlsx" id="SM3" mimetype="application/xlsx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table_4.xlsx" id="SM4" mimetype="application/xlsx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table_5.xlsx" id="SM5" mimetype="application/xlsx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table_6.xlsx" id="SM6" mimetype="application/xlsx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table_7.xlsx" id="SM7" mimetype="application/xlsx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table_8.xlsx" id="SM8" mimetype="application/xlsx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Data_Sheet_1.docx" id="SM9" mimetype="application/docx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Adasme</surname> <given-names>T.</given-names></name> <name><surname>Haeger</surname> <given-names>P.</given-names></name> <name><surname>Paula-Lima</surname> <given-names>A. C.</given-names></name> <name><surname>Espinoza</surname> <given-names>I.</given-names></name> <name><surname>Casas-Alarc&#x000F3;n</surname> <given-names>M. M.</given-names></name> <name><surname>Carrasco</surname> <given-names>M. A.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title>Involvement of ryanodine receptors in neurotrophin-induced hippocampal synaptic plasticity and spatial memory formation</article-title>. <source>Proc. Natl. Acad. Sci. U S A</source> <volume>108</volume>, <fpage>3029</fpage>&#x02013;<lpage>3034</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1013580108</pub-id><pub-id pub-id-type="pmid">21282625</pub-id></citation></ref>
<ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alcamo</surname> <given-names>E. A.</given-names></name> <name><surname>Chirivella</surname> <given-names>L.</given-names></name> <name><surname>Dautzenberg</surname> <given-names>M.</given-names></name> <name><surname>Dobreva</surname> <given-names>G.</given-names></name> <name><surname>Fari&#x000F1;as</surname> <given-names>I.</given-names></name> <name><surname>Grosschedl</surname> <given-names>R.</given-names></name> <etal/></person-group>. (<year>2008</year>). <article-title>Satb2 regulates callosal projection neuron identity in the developing cerebral cortex</article-title>. <source>Neuron</source> <volume>57</volume>, <fpage>364</fpage>&#x02013;<lpage>377</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2007.12.012</pub-id><pub-id pub-id-type="pmid">18255030</pub-id></citation></ref>
<ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Altschul</surname> <given-names>S. F.</given-names></name> <name><surname>Madden</surname> <given-names>T. L.</given-names></name> <name><surname>Schl&#x000E4;ffer</surname> <given-names>A. A.</given-names></name> <name><surname>Zhang</surname> <given-names>J.</given-names></name> <name><surname>Zhang</surname> <given-names>Z.</given-names></name> <name><surname>Miller</surname> <given-names>W.</given-names></name> <etal/></person-group>. (<year>1997</year>). <article-title>Gapped BLAST and PSI-BLAST: a new generation of protein database search programs</article-title>. <source>Nucleic Acids Res.</source> <volume>25</volume>, <fpage>3389</fpage>&#x02013;<lpage>3402</lpage>. <pub-id pub-id-type="doi">10.1093/nar/25.17.3389</pub-id><pub-id pub-id-type="pmid">9254694</pub-id></citation></ref>
<ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arlotta</surname> <given-names>P.</given-names></name> <name><surname>Molyneaux</surname> <given-names>B. J.</given-names></name> <name><surname>Chen</surname> <given-names>J.</given-names></name> <name><surname>Inoue</surname> <given-names>J.</given-names></name> <name><surname>Kominami</surname> <given-names>R.</given-names></name> <name><surname>Macklis</surname> <given-names>J. D.</given-names></name></person-group> (<year>2005</year>). <article-title>Neuronal subtype-specific genes that control corticospinal motor neuron development <italic>in vivo</italic></article-title>. <source>Neuron</source> <volume>45</volume>, <fpage>207</fpage>&#x02013;<lpage>221</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2004.12.036</pub-id><pub-id pub-id-type="pmid">15664173</pub-id></citation></ref>
<ref id="B5"><citation citation-type="web"><person-group person-group-type="author"><name><surname>Aronesty</surname> <given-names>E.</given-names></name></person-group> (<year>2011</year>). <article-title>ea-utils: command-line tools for processing biological sequencing data</article-title>. Available online at: <ext-link ext-link-type="uri" xlink:href="https://expressionanalysis.github.io/ea-utils/">https://expressionanalysis.github.io/ea-utils/</ext-link></citation></ref>
<ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Best</surname> <given-names>H. L.</given-names></name> <name><surname>Neverman</surname> <given-names>N. J.</given-names></name> <name><surname>Wicky</surname> <given-names>H. E.</given-names></name> <name><surname>Mitchell</surname> <given-names>N. L.</given-names></name> <name><surname>Leitch</surname> <given-names>B.</given-names></name> <name><surname>Hughes</surname> <given-names>S. M.</given-names></name></person-group> (<year>2017</year>). <article-title>Characterisation of early changes in ovine CLN5 and CLN6 Batten disease neural cultures for the rapid screening of therapeutics</article-title>. <source>Neurobiol. Dis.</source> <volume>100</volume>, <fpage>62</fpage>&#x02013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2017.01.001</pub-id><pub-id pub-id-type="pmid">28065762</pub-id></citation></ref>
<ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brettingham-Moore</surname> <given-names>K. H.</given-names></name> <name><surname>Taberlay</surname> <given-names>P. C.</given-names></name> <name><surname>Holloway</surname> <given-names>A. F.</given-names></name></person-group> (<year>2015</year>). <article-title>Interplay between transcription factors and the epigenome: insight from the role of RUNX1 in leukemia</article-title>. <source>Front. Immunol.</source> <volume>6</volume>:<fpage>499</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2015.00499</pub-id><pub-id pub-id-type="pmid">26483790</pub-id></citation></ref>
<ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Britanova</surname> <given-names>O.</given-names></name> <name><surname>de Juan Romero</surname> <given-names>C.</given-names></name> <name><surname>Cheung</surname> <given-names>A.</given-names></name> <name><surname>Kwan</surname> <given-names>K. Y.</given-names></name> <name><surname>Schwark</surname> <given-names>M.</given-names></name> <name><surname>Gyorgy</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2008</year>). <article-title>Satb2 is a postmitotic determinant for upper-layer neuron specification in the neocortex</article-title>. <source>Neuron</source> <volume>57</volume>, <fpage>378</fpage>&#x02013;<lpage>392</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2007.12.028</pub-id><pub-id pub-id-type="pmid">18255031</pub-id></citation></ref>
<ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>T.</given-names></name> <name><surname>Dent</surname> <given-names>S. Y. R.</given-names></name></person-group> (<year>2014</year>). <article-title>Chromatin modifiers: regulators of cellular differentiation</article-title>. <source>Nat. Rev. Genet.</source> <volume>15</volume>, <fpage>93</fpage>&#x02013;<lpage>106</lpage>. <pub-id pub-id-type="doi">10.1038/nrg3607</pub-id><pub-id pub-id-type="pmid">24366184</pub-id></citation></ref>
<ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>J.-G.</given-names></name> <name><surname>Rasin</surname> <given-names>M.-R.</given-names></name> <name><surname>Kwan</surname> <given-names>K. Y.</given-names></name> <name><surname>&#x00160;estan</surname> <given-names>N.</given-names></name></person-group> (<year>2005</year>). <article-title>Zfp312 is required for subcortical axonal projections and dendritic morphology of deep-layer pyramidal neurons of the cerebral cortex</article-title>. <source>Proc. Natl. Acad. Sci. U S A</source> <volume>102</volume>, <fpage>17792</fpage>&#x02013;<lpage>17797</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0509032102</pub-id><pub-id pub-id-type="pmid">16314561</pub-id></citation></ref>
<ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>B.</given-names></name> <name><surname>Schaevitz</surname> <given-names>L. R.</given-names></name> <name><surname>McConnell</surname> <given-names>S. K.</given-names></name></person-group> (<year>2005</year>). <article-title><italic>Fezl</italic> regulates the differentiation and axon targeting of layer 5 subcortical projection neurons in cerebral cortex</article-title>. <source>Proc. Natl. Acad. Sci. U S A</source> <volume>102</volume>, <fpage>17184</fpage>&#x02013;<lpage>17189</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0508732102</pub-id><pub-id pub-id-type="pmid">16284245</pub-id></citation></ref>
<ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Deneris</surname> <given-names>E. S.</given-names></name> <name><surname>Hobert</surname> <given-names>O.</given-names></name></person-group> (<year>2014</year>). <article-title>Maintenance of postmitotic neuronal cell identity</article-title>. <source>Nat. Neurosci.</source> <volume>17</volume>, <fpage>899</fpage>&#x02013;<lpage>907</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3731</pub-id><pub-id pub-id-type="pmid">24929660</pub-id></citation></ref>
<ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Desmaris</surname> <given-names>N.</given-names></name> <name><surname>Bosch</surname> <given-names>A.</given-names></name> <name><surname>Sala&#x000FC;n</surname> <given-names>C.</given-names></name> <name><surname>Petit</surname> <given-names>C.</given-names></name> <name><surname>Pr&#x000E9;vost</surname> <given-names>M. C.</given-names></name> <name><surname>Tordo</surname> <given-names>N.</given-names></name> <etal/></person-group>. (<year>2001</year>). <article-title>Production and neurotropism of lentivirus vectors pseudotyped with lyssavirus envelope glycoproteins</article-title>. <source>Mol. Ther.</source> <volume>4</volume>, <fpage>149</fpage>&#x02013;<lpage>156</lpage>. <pub-id pub-id-type="doi">10.1006/mthe.2001.0431</pub-id><pub-id pub-id-type="pmid">11482987</pub-id></citation></ref>
<ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dittgen</surname> <given-names>T.</given-names></name> <name><surname>Nimmerjahn</surname> <given-names>A.</given-names></name> <name><surname>Komai</surname> <given-names>S.</given-names></name> <name><surname>Licznerski</surname> <given-names>P.</given-names></name> <name><surname>Waters</surname> <given-names>J.</given-names></name> <name><surname>Margrie</surname> <given-names>T. W.</given-names></name> <etal/></person-group>. (<year>2004</year>). <article-title>Lentivirus-based genetic manipulations of cortical neurons and their optical and electrophysiological monitoring <italic>in vivo</italic></article-title>. <source>Proc. Natl. Acad. Sci. U S A</source> <volume>101</volume>, <fpage>18206</fpage>&#x02013;<lpage>18211</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0407976101</pub-id><pub-id pub-id-type="pmid">15608064</pub-id></citation></ref>
<ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Domanskyi</surname> <given-names>A.</given-names></name> <name><surname>Alter</surname> <given-names>H.</given-names></name> <name><surname>Vogt</surname> <given-names>M. A.</given-names></name> <name><surname>Gass</surname> <given-names>P.</given-names></name> <name><surname>Vinnikov</surname> <given-names>I. A.</given-names></name></person-group> (<year>2014</year>). <article-title>Transcription factors Foxa1 and Foxa2 are required for adult dopamine neurons maintenance</article-title>. <source>Front. Cell. Neurosci.</source> <volume>8</volume>:<fpage>275</fpage>. <pub-id pub-id-type="doi">10.3389/fncel.2014.00275</pub-id><pub-id pub-id-type="pmid">25249938</pub-id></citation></ref>
<ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fellmann</surname> <given-names>C.</given-names></name> <name><surname>Hoffmann</surname> <given-names>T.</given-names></name> <name><surname>Sridhar</surname> <given-names>V.</given-names></name> <name><surname>Hopfgartner</surname> <given-names>B.</given-names></name> <name><surname>Muhar</surname> <given-names>M.</given-names></name> <name><surname>Roth</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>An optimized microRNA backbone for effective single-copy RNAi</article-title>. <source>Cell Rep.</source> <volume>5</volume>, <fpage>1704</fpage>&#x02013;<lpage>1713</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2013.11.020</pub-id><pub-id pub-id-type="pmid">24332856</pub-id></citation></ref>
<ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname> <given-names>S.</given-names></name> <name><surname>Zheng</surname> <given-names>C.</given-names></name> <name><surname>Doughty</surname> <given-names>M. L.</given-names></name> <name><surname>Losos</surname> <given-names>K.</given-names></name> <name><surname>Didkovsky</surname> <given-names>N.</given-names></name> <name><surname>Schambra</surname> <given-names>U. B.</given-names></name> <etal/></person-group>. (<year>2003</year>). <article-title>A gene expression atlas of the central nervous system based on bacterial artificial chromosomes</article-title>. <source>Nature</source> <volume>425</volume>, <fpage>917</fpage>&#x02013;<lpage>926</lpage>. <pub-id pub-id-type="doi">10.1038/nature02033</pub-id><pub-id pub-id-type="pmid">14586460</pub-id></citation></ref>
<ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname> <given-names>C.</given-names></name> <name><surname>Eckler</surname> <given-names>M. J.</given-names></name> <name><surname>McKenna</surname> <given-names>W. L.</given-names></name> <name><surname>McKinsey</surname> <given-names>G. L.</given-names></name> <name><surname>Rubenstein</surname> <given-names>J. L. R.</given-names></name> <name><surname>Bin</surname> <given-names>C.</given-names></name></person-group> (<year>2013</year>). <article-title>Fezf2 expression identifies a multipotent progenitor for neocortical projection neurons, astrocytes, and oligodendrocytes</article-title>. <source>Neuron</source> <volume>80</volume>, <fpage>1167</fpage>&#x02013;<lpage>1174</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2013.09.037</pub-id><pub-id pub-id-type="pmid">24314728</pub-id></citation></ref>
<ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Han</surname> <given-names>W.</given-names></name> <name><surname>Kwan</surname> <given-names>K. Y.</given-names></name> <name><surname>Shim</surname> <given-names>S.</given-names></name> <name><surname>Lam</surname> <given-names>M. M.</given-names></name> <name><surname>Shin</surname> <given-names>Y.</given-names></name> <name><surname>Xu</surname> <given-names>X.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title>TBR1 directly represses Fezf2 to control the laminar origin and development of the corticospinal tract</article-title>. <source>Proc. Natl. Acad. Sci. U S A</source> <volume>108</volume>, <fpage>3041</fpage>&#x02013;<lpage>3046</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1016723108</pub-id><pub-id pub-id-type="pmid">21285371</pub-id></citation></ref>
<ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Herglotz</surname> <given-names>J.</given-names></name> <name><surname>Kuvardina</surname> <given-names>O. N.</given-names></name> <name><surname>Kolodziej</surname> <given-names>S.</given-names></name> <name><surname>Kumar</surname> <given-names>A.</given-names></name> <name><surname>Hussong</surname> <given-names>H.</given-names></name> <name><surname>Grez</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Histone arginine methylation keeps RUNX1 target genes in an intermediate state</article-title>. <source>Oncogene</source> <volume>32</volume>, <fpage>2565</fpage>&#x02013;<lpage>2575</lpage>. <pub-id pub-id-type="doi">10.1038/onc.2012.274</pub-id><pub-id pub-id-type="pmid">22777353</pub-id></citation></ref>
<ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hirata</surname> <given-names>T.</given-names></name> <name><surname>Nakazawa</surname> <given-names>M.</given-names></name> <name><surname>Muraoka</surname> <given-names>O.</given-names></name> <name><surname>Nakayama</surname> <given-names>R.</given-names></name> <name><surname>Suda</surname> <given-names>Y.</given-names></name> <name><surname>Hibi</surname> <given-names>M.</given-names></name></person-group> (<year>2006</year>). <article-title>Zinc-finger genes Fez and Fez-like function in the establishment of diencephalon subdivisions</article-title>. <source>Development</source> <volume>133</volume>, <fpage>3993</fpage>&#x02013;<lpage>4004</lpage>. <pub-id pub-id-type="doi">10.1242/dev.02585</pub-id><pub-id pub-id-type="pmid">16971467</pub-id></citation></ref>
<ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hirata</surname> <given-names>T.</given-names></name> <name><surname>Suda</surname> <given-names>Y.</given-names></name> <name><surname>Nakao</surname> <given-names>K.</given-names></name> <name><surname>Narimatsu</surname> <given-names>M.</given-names></name> <name><surname>Hirano</surname> <given-names>T.</given-names></name> <name><surname>Hibi</surname> <given-names>M.</given-names></name></person-group> (<year>2004</year>). <article-title>Zinc finger gene fez-like functions in the formation of subplate neurons and thalamocortical axons</article-title>. <source>Dev. Dyn.</source> <volume>230</volume>, <fpage>546</fpage>&#x02013;<lpage>556</lpage>. <pub-id pub-id-type="doi">10.1002/dvdy.20068</pub-id><pub-id pub-id-type="pmid">15188439</pub-id></citation></ref>
<ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>D. W.</given-names></name> <name><surname>Sherman</surname> <given-names>B. T.</given-names></name> <name><surname>Tan</surname> <given-names>Q.</given-names></name> <name><surname>Collins</surname> <given-names>J. R.</given-names></name> <name><surname>Alvord</surname> <given-names>W. G.</given-names></name> <name><surname>Roayaei</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2007</year>). <article-title>The DAVID gene functional classification tool: a novel biological module-centric algorithm to functionally analyse large gene sets</article-title>. <source>Genome Biol.</source> <volume>8</volume>:<fpage>R183</fpage>. <pub-id pub-id-type="doi">10.1186/gb-2007-8-9-r183</pub-id><pub-id pub-id-type="pmid">17784955</pub-id></citation></ref>
<ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Inoue</surname> <given-names>K.</given-names></name> <name><surname>Terashima</surname> <given-names>T.</given-names></name> <name><surname>Nishikawa</surname> <given-names>T.</given-names></name> <name><surname>Takumi</surname> <given-names>T.</given-names></name></person-group> (<year>2004</year>). <article-title>Fez1 is layer-specifically expressed in the adult mouse neocortex</article-title>. <source>Eur. J. Neurosci.</source> <volume>20</volume>, <fpage>2909</fpage>&#x02013;<lpage>2916</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.2004.03763.x</pub-id><pub-id pub-id-type="pmid">15579145</pub-id></citation></ref>
<ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jaitner</surname> <given-names>C.</given-names></name> <name><surname>Reddy</surname> <given-names>C.</given-names></name> <name><surname>Abentung</surname> <given-names>A.</given-names></name> <name><surname>Whittle</surname> <given-names>N.</given-names></name> <name><surname>Rieder</surname> <given-names>D.</given-names></name> <name><surname>Delekate</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Satb2 determines miRNA expression and long-term memory in the adult central nervous system</article-title>. <source>Elife</source> <volume>5</volume>:<fpage>e17361</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.17361</pub-id><pub-id pub-id-type="pmid">27897969</pub-id></citation></ref>
<ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kadkhodaei</surname> <given-names>B.</given-names></name> <name><surname>Ito</surname> <given-names>T.</given-names></name> <name><surname>Joodmardi</surname> <given-names>E.</given-names></name> <name><surname>Mattsson</surname> <given-names>B.</given-names></name> <name><surname>Rouillard</surname> <given-names>C.</given-names></name> <name><surname>Carta</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2009</year>). <article-title>Nurr1 is required for maintenance of maturing and adult midbrain dopamine neurons</article-title>. <source>J. Neurosci.</source> <volume>29</volume>, <fpage>15923</fpage>&#x02013;<lpage>15932</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3910-09.2009</pub-id><pub-id pub-id-type="pmid">20016108</pub-id></citation></ref>
<ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>D.</given-names></name> <name><surname>Pertea</surname> <given-names>G.</given-names></name> <name><surname>Trapnell</surname> <given-names>C.</given-names></name> <name><surname>Pimentel</surname> <given-names>H.</given-names></name> <name><surname>Kelley</surname> <given-names>R.</given-names></name> <name><surname>Salzberg</surname> <given-names>S. L.</given-names></name></person-group> (<year>2013</year>). <article-title>TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions</article-title>. <source>Genome Biol.</source> <volume>14</volume>:<fpage>R36</fpage>. <pub-id pub-id-type="doi">10.1186/gb-2013-14-4-r36</pub-id><pub-id pub-id-type="pmid">23618408</pub-id></citation></ref>
<ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kwan</surname> <given-names>K. Y.</given-names></name> <name><surname>&#x00160;estan</surname> <given-names>N.</given-names></name> <name><surname>Anton</surname> <given-names>E. S.</given-names></name></person-group> (<year>2012</year>). <article-title>Transcriptional co-regulation of neuronal migration and laminar identity in the neocortex</article-title>. <source>Development</source> <volume>139</volume>, <fpage>1535</fpage>&#x02013;<lpage>1546</lpage>. <pub-id pub-id-type="doi">10.1242/dev.069963</pub-id><pub-id pub-id-type="pmid">22492350</pub-id></citation></ref>
<ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>H.</given-names></name> <name><surname>Handsaker</surname> <given-names>B.</given-names></name> <name><surname>Wysoker</surname> <given-names>A.</given-names></name> <name><surname>Fennell</surname> <given-names>T.</given-names></name> <name><surname>Ruan</surname> <given-names>J.</given-names></name> <name><surname>Homer</surname> <given-names>N.</given-names></name> <etal/></person-group>. (<year>2009</year>). <article-title>The sequence alignment/map format and SAMtools</article-title>. <source>Bioinformatics</source> <volume>25</volume>, <fpage>2078</fpage>&#x02013;<lpage>2079</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btp352</pub-id><pub-id pub-id-type="pmid">19505943</pub-id></citation></ref>
<ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Linterman</surname> <given-names>K. S.</given-names></name> <name><surname>Palmer</surname> <given-names>D. N.</given-names></name> <name><surname>Kay</surname> <given-names>G. W.</given-names></name> <name><surname>Barry</surname> <given-names>L. A.</given-names></name> <name><surname>Mitchell</surname> <given-names>N. L.</given-names></name> <name><surname>McFarlane</surname> <given-names>R. G.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title>Lentiviral-mediated gene transfer to the sheep brain: implications for gene therapy in Batten disease</article-title>. <source>Hum. Gene Ther.</source> <volume>22</volume>, <fpage>1011</fpage>&#x02013;<lpage>1020</lpage>. <pub-id pub-id-type="doi">10.1089/hum.2011.026</pub-id><pub-id pub-id-type="pmid">21595499</pub-id></citation></ref>
<ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>C.</given-names></name> <name><surname>Maejima</surname> <given-names>T.</given-names></name> <name><surname>Wyler</surname> <given-names>S. C.</given-names></name> <name><surname>Casadesus</surname> <given-names>G.</given-names></name> <name><surname>Herlitze</surname> <given-names>S.</given-names></name> <name><surname>Deneris</surname> <given-names>E. S.</given-names></name></person-group> (<year>2010</year>). <article-title><italic>Pet-1</italic> is required across different stages of life to regulate serotonergic function</article-title>. <source>Nat. Neurosci.</source> <volume>13</volume>, <fpage>1190</fpage>&#x02013;<lpage>1198</lpage>. <pub-id pub-id-type="doi">10.1038/nn.2623</pub-id><pub-id pub-id-type="pmid">20818386</pub-id></citation></ref>
<ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lodato</surname> <given-names>S.</given-names></name> <name><surname>Molyneaux</surname> <given-names>B. J.</given-names></name> <name><surname>Zuccaro</surname> <given-names>E.</given-names></name> <name><surname>Goff</surname> <given-names>L. A.</given-names></name> <name><surname>Chen</surname> <given-names>H.-H.</given-names></name> <name><surname>Yuan</surname> <given-names>W.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>Gene co-regulation by Fezf2 selects neurotransmitter identity and connectivity of corticospinal neurons</article-title>. <source>Nat. Neurosci.</source> <volume>17</volume>, <fpage>1046</fpage>&#x02013;<lpage>1054</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3757</pub-id><pub-id pub-id-type="pmid">24997765</pub-id></citation></ref>
<ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Love</surname> <given-names>M. I.</given-names></name> <name><surname>Huber</surname> <given-names>W.</given-names></name> <name><surname>Anders</surname> <given-names>S.</given-names></name></person-group> (<year>2014</year>). <article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title>. <source>Genome Biol.</source> <volume>15</volume>:<fpage>550</fpage>. <pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id><pub-id pub-id-type="pmid">25516281</pub-id></citation></ref>
<ref id="B37"><citation citation-type="web"><person-group person-group-type="author"><name><surname>Lucas</surname> <given-names>A.</given-names></name></person-group> (<year>2009</year>). <article-title>Another multidimensional analysis package</article-title>. Available online at: <ext-link ext-link-type="uri" xlink:href="http://mulcyber.toulouse.inra.fr/projects/amap/">http://mulcyber.toulouse.inra.fr/projects/amap/</ext-link></citation></ref>
<ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marambaud</surname> <given-names>P.</given-names></name> <name><surname>Dreses-Werringloer</surname> <given-names>U.</given-names></name> <name><surname>Vingtdeux</surname> <given-names>V.</given-names></name></person-group> (<year>2009</year>). <article-title>Calcium signaling in neurodegeneration</article-title>. <source>Mol. Neurodegener.</source> <volume>4</volume>:<fpage>20</fpage>. <pub-id pub-id-type="doi">10.1186/1750-1326-4-20</pub-id><pub-id pub-id-type="pmid">19419557</pub-id></citation></ref>
<ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McKenna</surname> <given-names>W. L.</given-names></name> <name><surname>Betancourt</surname> <given-names>J.</given-names></name> <name><surname>Larkin</surname> <given-names>K. A.</given-names></name> <name><surname>Abrams</surname> <given-names>B.</given-names></name> <name><surname>Guo</surname> <given-names>C.</given-names></name> <name><surname>Rubenstein</surname> <given-names>J. L. R.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title><italic>Tbr1</italic> and <italic>Fezf2</italic> regulate alternate corticofugal neuronal identities during neocortical development</article-title>. <source>J. Neurosci.</source> <volume>31</volume>, <fpage>549</fpage>&#x02013;<lpage>564</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4131-10.2011</pub-id><pub-id pub-id-type="pmid">21228164</pub-id></citation></ref>
<ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Molyneaux</surname> <given-names>B. J.</given-names></name> <name><surname>Arlotta</surname> <given-names>P.</given-names></name> <name><surname>Hirata</surname> <given-names>T.</given-names></name> <name><surname>Hibi</surname> <given-names>M.</given-names></name> <name><surname>Macklis</surname> <given-names>J. D.</given-names></name></person-group> (<year>2005</year>). <article-title><italic>Fezl</italic> is required for the birth and specification of corticospinal motor neurons</article-title>. <source>Neuron</source> <volume>47</volume>, <fpage>817</fpage>&#x02013;<lpage>831</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2005.08.030</pub-id><pub-id pub-id-type="pmid">16157277</pub-id></citation></ref>
<ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Molyneaux</surname> <given-names>B. J.</given-names></name> <name><surname>Arlotta</surname> <given-names>P.</given-names></name> <name><surname>Menezes</surname> <given-names>J. R. L.</given-names></name> <name><surname>Macklis</surname> <given-names>J. D.</given-names></name></person-group> (<year>2007</year>). <article-title>Neuronal subtype specification in the cerebral cortex</article-title>. <source>Nat. Rev. Neurosci.</source> <volume>8</volume>, <fpage>427</fpage>&#x02013;<lpage>437</lpage>. <pub-id pub-id-type="doi">10.1038/nrn2151</pub-id><pub-id pub-id-type="pmid">17514196</pub-id></citation></ref>
<ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname> <given-names>C. B.</given-names></name> <name><surname>Guthrie</surname> <given-names>E. H.</given-names></name> <name><surname>Huang</surname> <given-names>M. T. H.</given-names></name> <name><surname>Taxman</surname> <given-names>D. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Short hairpin RNA (shRNA): design, delivery, and assessment of gene knockdown</article-title>. <source>Methods Mol. Biol.</source> <volume>629</volume>, <fpage>141</fpage>&#x02013;<lpage>158</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-60761-657-3_10</pub-id><pub-id pub-id-type="pmid">20387148</pub-id></citation></ref>
<ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ozdinler</surname> <given-names>P. H.</given-names></name> <name><surname>Benn</surname> <given-names>S.</given-names></name> <name><surname>Yamamoto</surname> <given-names>T. H.</given-names></name> <name><surname>Guzel</surname> <given-names>M.</given-names></name> <name><surname>Brown</surname> <given-names>R. H.</given-names> <suffix>Jr.</suffix></name> <name><surname>Macklis</surname> <given-names>J. D.</given-names></name></person-group> (<year>2011</year>). <article-title>Corticospinal motor neurons and related subcerebral projection neurons undergo early and specific neurodegeneration in hSOD1<sup>G93A</sup> transgenic ALS mice</article-title>. <source>J. Neurosci.</source> <volume>31</volume>, <fpage>4166</fpage>&#x02013;<lpage>4177</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4184-10.2011</pub-id><pub-id pub-id-type="pmid">21411657</pub-id></citation></ref>
<ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname> <given-names>S. R.</given-names></name> <name><surname>Bhumbra</surname> <given-names>S. S.</given-names></name> <name><surname>Paknikar</surname> <given-names>R. S.</given-names></name> <name><surname>Dressler</surname> <given-names>G. R.</given-names></name></person-group> (<year>2012</year>). <article-title>Epigenetic mechanisms of Groucho/Grg/TLE mediated transcriptional repression</article-title>. <source>Mol. Cell</source> <volume>45</volume>, <fpage>185</fpage>&#x02013;<lpage>195</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2011.11.007</pub-id><pub-id pub-id-type="pmid">22169276</pub-id></citation></ref>
<ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pfaffl</surname> <given-names>M. W.</given-names></name></person-group> (<year>2001</year>). <article-title>A new mathematical model for relative quantification in real-time RT-PCR</article-title>. <source>Nucleic Acids Res.</source> <volume>29</volume>:<fpage>e45</fpage>. <pub-id pub-id-type="doi">10.1093/nar/29.9.e45</pub-id><pub-id pub-id-type="pmid">11328886</pub-id></citation></ref>
<ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Quinlan</surname> <given-names>A. R.</given-names></name> <name><surname>Hall</surname> <given-names>I. M.</given-names></name></person-group> (<year>2010</year>). <article-title>BEDTools: a flexible suite of utilities for comparing genomic features</article-title>. <source>Bioinformatics</source> <volume>26</volume>, <fpage>841</fpage>&#x02013;<lpage>842</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btq033</pub-id><pub-id pub-id-type="pmid">20110278</pub-id></citation></ref>
<ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname> <given-names>M. D.</given-names></name> <name><surname>McCarthy</surname> <given-names>D. J.</given-names></name> <name><surname>Smyth</surname> <given-names>G. K.</given-names></name></person-group> (<year>2010</year>). <article-title>edgeR: a Bioconductor package for differential expression analysis of digital gene expression data</article-title>. <source>Bioinformatics</source> <volume>26</volume>, <fpage>139</fpage>&#x02013;<lpage>140</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btp616</pub-id><pub-id pub-id-type="pmid">19910308</pub-id></citation></ref>
<ref id="B51"><citation citation-type="book"><person-group person-group-type="author"><collab>RStudio Team</collab></person-group>. (<year>2015</year>). <source>RStudio: Integrated Development for R.</source> <publisher-loc>Boston, MA</publisher-loc>: <publisher-name>RStudio, Inc</publisher-name>. Available online at: <ext-link ext-link-type="uri" xlink:href="http://www.rstudio.com">http://www.rstudio.com</ext-link></citation></ref>
<ref id="B52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Satoh</surname> <given-names>J. I.</given-names></name> <name><surname>Yamamoto</surname> <given-names>Y.</given-names></name> <name><surname>Asahina</surname> <given-names>N.</given-names></name> <name><surname>Kitano</surname> <given-names>S.</given-names></name> <name><surname>Kino</surname> <given-names>Y.</given-names></name></person-group> (<year>2014</year>). <article-title>RNA-Seq data mining: downregulation of NeuroD6 serves as a possible biomarker for alzheimer&#x02019;s disease brains</article-title>. <source>Dis. Markers</source> <volume>2014</volume>:<fpage>123165</fpage>. <pub-id pub-id-type="doi">10.1155/2014/123165</pub-id><pub-id pub-id-type="pmid">25548427</pub-id></citation></ref>
<ref id="B53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schoderboeck</surname> <given-names>L.</given-names></name> <name><surname>Riad</surname> <given-names>S.</given-names></name> <name><surname>Bokor</surname> <given-names>A. M.</given-names></name> <name><surname>Wicky</surname> <given-names>H. E.</given-names></name> <name><surname>Strauss</surname> <given-names>M.</given-names></name> <name><surname>Bostina</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2015</year>). <article-title>Chimeric rabies SADB19-VSVg-pseudotyped lentiviral vectors mediate long-range retrograde transduction from the mouse spinal cord</article-title>. <source>Gene Ther.</source> <volume>22</volume>, <fpage>357</fpage>&#x02013;<lpage>364</lpage>. <pub-id pub-id-type="doi">10.1038/gt.2015.3</pub-id><pub-id pub-id-type="pmid">25630949</pub-id></citation></ref>
<ref id="B71"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shepherd</surname> <given-names>G. M.</given-names></name></person-group> (<year>2013</year>). <article-title>Corticostriatal connectivity and its role in disease</article-title>. <source>Nat. Rev. Neurosci.</source> <volume>14</volume>, <fpage>278</fpage>&#x02013;<lpage>291</lpage>. <pub-id pub-id-type="doi">10.1038/nrn3469</pub-id><pub-id pub-id-type="pmid">23511908</pub-id></citation></ref>
<ref id="B54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shu</surname> <given-names>X.-S.</given-names></name> <name><surname>Li</surname> <given-names>L.</given-names></name> <name><surname>Ji</surname> <given-names>M.</given-names></name> <name><surname>Cheng</surname> <given-names>Y.</given-names></name> <name><surname>Ying</surname> <given-names>J.</given-names></name> <name><surname>Fan</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>FEZF2, a novel 3p14 tumor suppressor gene, represses oncogene EZH2 and MDM2 expression and is frequently methylated in nasopharyngeal carcinoma</article-title>. <source>Carcinogenesis</source> <volume>34</volume>, <fpage>1984</fpage>&#x02013;<lpage>1993</lpage>. <pub-id pub-id-type="doi">10.1093/carcin/bgt165</pub-id><pub-id pub-id-type="pmid">23677067</pub-id></citation></ref>
<ref id="B55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname> <given-names>C. L.</given-names></name> <name><surname>Goldsmith</surname> <given-names>C. A. W.</given-names></name> <name><surname>Eppig</surname> <given-names>J. T.</given-names></name></person-group> (<year>2004</year>). <article-title>The mammalian phenotype ontology as a tool for annotating, analyzing and comparing phenotypic information</article-title>. <source>Genome Biol.</source> <volume>6</volume>:<fpage>R7</fpage>. <pub-id pub-id-type="doi">10.1186/gb-2004-6-1-r7</pub-id><pub-id pub-id-type="pmid">15642099</pub-id></citation></ref>
<ref id="B56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Song</surname> <given-names>N.-N.</given-names></name> <name><surname>Xiu</surname> <given-names>J.-B.</given-names></name> <name><surname>Huang</surname> <given-names>Y.</given-names></name> <name><surname>Chen</surname> <given-names>J.-Y.</given-names></name> <name><surname>Zhang</surname> <given-names>L.</given-names></name> <name><surname>Gutknecht</surname> <given-names>L.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title>Adult raphe-specific deletion of Lmx1b leads to central serotonin deficiency</article-title>. <source>PLoS One</source> <volume>6</volume>:<fpage>e15998</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0015998</pub-id><pub-id pub-id-type="pmid">21246047</pub-id></citation></ref>
<ref id="B57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Spruston</surname> <given-names>N.</given-names></name></person-group> (<year>2008</year>). <article-title>Pyramidal neurons: dendritic structure and synaptic integration</article-title>. <source>Nat. Rev. Neurosci.</source> <volume>9</volume>, <fpage>206</fpage>&#x02013;<lpage>221</lpage>. <pub-id pub-id-type="doi">10.1038/nrn2286</pub-id><pub-id pub-id-type="pmid">18270515</pub-id></citation></ref>
<ref id="B58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Srinivasan</surname> <given-names>K.</given-names></name> <name><surname>Leone</surname> <given-names>D. P.</given-names></name> <name><surname>Bateson</surname> <given-names>R. K.</given-names></name> <name><surname>Dobreva</surname> <given-names>G.</given-names></name> <name><surname>Kohwi</surname> <given-names>Y.</given-names></name> <name><surname>Kohwi-Shigematsu</surname> <given-names>T.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>A network of genetic repression and derepression specifies projection fates in the developing neocortex</article-title>. <source>Proc. Natl. Acad. Sci. U S A</source> <volume>109</volume>, <fpage>19071</fpage>&#x02013;<lpage>19078</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1216793109</pub-id><pub-id pub-id-type="pmid">23144223</pub-id></citation></ref>
<ref id="B59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tantirigama</surname> <given-names>M. L. S.</given-names></name> <name><surname>Oswald</surname> <given-names>M. J.</given-names></name> <name><surname>Clare</surname> <given-names>A. J.</given-names></name> <name><surname>Wicky</surname> <given-names>H. E.</given-names></name> <name><surname>Day</surname> <given-names>R. C.</given-names></name> <name><surname>Hughes</surname> <given-names>S. M.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Fezf2 expression in layer 5 projection neurons of mature mouse motor cortex</article-title>. <source>J. Comp. Neurol.</source> <volume>524</volume>, <fpage>829</fpage>&#x02013;<lpage>845</lpage>. <pub-id pub-id-type="doi">10.1002/cne.23875</pub-id><pub-id pub-id-type="pmid">26234885</pub-id></citation></ref>
<ref id="B60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tantirigama</surname> <given-names>M. L. S.</given-names></name> <name><surname>Oswald</surname> <given-names>M. J.</given-names></name> <name><surname>Duynstee</surname> <given-names>C.</given-names></name> <name><surname>Hughes</surname> <given-names>S. M.</given-names></name> <name><surname>Empson</surname> <given-names>R. M.</given-names></name></person-group> (<year>2014</year>). <article-title>Expression of the developmental transcription factor <italic>Fezf2</italic> identifies a distinct subpopulation of layer 5 intratelencephalic-projection neurons in mature mouse motor cortex</article-title>. <source>J. Neurosci.</source> <volume>34</volume>, <fpage>4303</fpage>&#x02013;<lpage>4308</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3111-13.2014</pub-id><pub-id pub-id-type="pmid">24647950</pub-id></citation></ref>
<ref id="B61"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tsarovina</surname> <given-names>K.</given-names></name> <name><surname>Reiff</surname> <given-names>T.</given-names></name> <name><surname>Stubbusch</surname> <given-names>J.</given-names></name> <name><surname>Kurek</surname> <given-names>D.</given-names></name> <name><surname>Grosveld</surname> <given-names>F. G.</given-names></name> <name><surname>Parlato</surname> <given-names>R.</given-names></name> <etal/></person-group>. (<year>2010</year>). <article-title>The Gata3 transcription factor is required for the survival of embryonic and adult sympathetic neurons</article-title>. <source>J. Neurosci.</source> <volume>30</volume>, <fpage>10833</fpage>&#x02013;<lpage>10843</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0175-10.2010</pub-id><pub-id pub-id-type="pmid">20702712</pub-id></citation></ref>
<ref id="B62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>J.</given-names></name> <name><surname>Duncan</surname> <given-names>D.</given-names></name> <name><surname>Shi</surname> <given-names>Z.</given-names></name> <name><surname>Zhang</surname> <given-names>B.</given-names></name></person-group> (<year>2013</year>). <article-title>WEB-based gene set analysis toolkit (WebGestalt): update 2013</article-title>. <source>Nucleic Acids Res.</source> <volume>41</volume>, <fpage>W77</fpage>&#x02013;<lpage>W83</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkt439</pub-id><pub-id pub-id-type="pmid">23703215</pub-id></citation></ref>
<ref id="B63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>X.-S.</given-names></name> <name><surname>Simmons</surname> <given-names>Z.</given-names></name> <name><surname>Liu</surname> <given-names>W.</given-names></name> <name><surname>Boyer</surname> <given-names>P. J.</given-names></name> <name><surname>Connor</surname> <given-names>J. R.</given-names></name></person-group> (<year>2007</year>). <article-title>Differential expression of genes in amyotrophic lateral sclerosis revealed by profiling of post mortem cortex</article-title>. <source>Amyotroph. Lateral Scler.</source> <volume>7</volume>, <fpage>201</fpage>&#x02013;<lpage>216</lpage>. <pub-id pub-id-type="doi">10.1080/17482960600947689</pub-id><pub-id pub-id-type="pmid">17127558</pub-id></citation></ref>
<ref id="B64"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xia</surname> <given-names>J.</given-names></name> <name><surname>Gill</surname> <given-names>E.</given-names></name> <name><surname>Hancock</surname> <given-names>R. E. W.</given-names></name></person-group> (<year>2015</year>). <article-title>NetworkAnalyst for statistical, visual and network-based approaches for meta-analysis of expression data</article-title>. <source>Nat. Protoc.</source> <volume>10</volume>, <fpage>823</fpage>&#x02013;<lpage>844</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2015.052</pub-id><pub-id pub-id-type="pmid">25950236</pub-id></citation></ref>
<ref id="B65"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname> <given-names>F.</given-names></name> <name><surname>Xiao</surname> <given-names>P.</given-names></name> <name><surname>Chen</surname> <given-names>D.</given-names></name> <name><surname>Xu</surname> <given-names>L.</given-names></name> <name><surname>Zhang</surname> <given-names>B.</given-names></name></person-group> (<year>2012</year>). <article-title>miRDeepFinder: a miRNA analysis tool for deep sequencing of plant small RNAs</article-title>. <source>Plant Mol. Biol.</source> <volume>80</volume>, <fpage>75</fpage>&#x02013;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1007/s11103-012-9885-2</pub-id><pub-id pub-id-type="pmid">22290409</pub-id></citation></ref>
<ref id="B66"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>C.</given-names></name> <name><surname>Wang</surname> <given-names>H.</given-names></name> <name><surname>Qiao</surname> <given-names>T.</given-names></name> <name><surname>Yang</surname> <given-names>B.</given-names></name> <name><surname>Aliaga</surname> <given-names>L.</given-names></name> <name><surname>Qiu</surname> <given-names>L.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>Partial loss of TDP-43 function causes phenotypes of amyotrophic lateral sclerosis</article-title>. <source>Proc. Natl. Acad. Sci. U S A</source> <volume>111</volume>, <fpage>E1121</fpage>&#x02013;<lpage>E1129</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1322641111</pub-id><pub-id pub-id-type="pmid">24616503</pub-id></citation></ref>
<ref id="B67"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname> <given-names>J.</given-names></name> <name><surname>Coulouris</surname> <given-names>G.</given-names></name> <name><surname>Zaretskaya</surname> <given-names>I.</given-names></name> <name><surname>Cutcutache</surname> <given-names>I.</given-names></name> <name><surname>Rozen</surname> <given-names>S.</given-names></name> <name><surname>Madden</surname> <given-names>T. L.</given-names></name></person-group> (<year>2012</year>). <article-title>Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction</article-title>. <source>BMC Bioinformatics</source> <volume>13</volume>:<fpage>134</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2105-13-134</pub-id><pub-id pub-id-type="pmid">22708584</pub-id></citation></ref>
<ref id="B68"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zeisel</surname> <given-names>A.</given-names></name> <name><surname>Mu&#x000F1;oz-Manchado</surname> <given-names>A. B.</given-names></name> <name><surname>Codeluppi</surname> <given-names>S.</given-names></name> <name><surname>L&#x000F6;nnerberg</surname> <given-names>P.</given-names></name> <name><surname>La Manno</surname> <given-names>G.</given-names></name> <name><surname>Jur&#x000E9;us</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2015</year>). <article-title>Cell types in the mouse cortex and hippocampus revealed by single-cell RNA-seq</article-title>. <source>Science</source> <volume>347</volume>, <fpage>1138</fpage>&#x02013;<lpage>1142</lpage>. <pub-id pub-id-type="doi">10.1126/science.aaa1934</pub-id><pub-id pub-id-type="pmid">25700174</pub-id></citation></ref>
<ref id="B69"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>S.</given-names></name> <name><surname>Li</surname> <given-names>J.</given-names></name> <name><surname>Lea</surname> <given-names>R.</given-names></name> <name><surname>Vleminckx</surname> <given-names>K.</given-names></name> <name><surname>Amaya</surname> <given-names>E.</given-names></name></person-group> (<year>2014</year>). <article-title>Fezf2 promotes neuronal differentiation through localised activation of Wnt/&#x003B2;-catenin signalling during forebrain development</article-title>. <source>Development</source> <volume>141</volume>, <fpage>4794</fpage>&#x02013;<lpage>4805</lpage>. <pub-id pub-id-type="doi">10.1242/dev.115691</pub-id><pub-id pub-id-type="pmid">25468942</pub-id></citation></ref>
<ref id="B70"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zufferey</surname> <given-names>R.</given-names></name> <name><surname>Nagy</surname> <given-names>D.</given-names></name> <name><surname>Mandel</surname> <given-names>R. J.</given-names></name> <name><surname>Naldini</surname> <given-names>L.</given-names></name> <name><surname>Trono</surname> <given-names>D.</given-names></name></person-group> (<year>1997</year>). <article-title>Multiply attenuated lentiviral vector achieves efficient gene delivery <italic>in vivo</italic></article-title>. <source>Nat. Biotechnol.</source> <volume>15</volume>, <fpage>871</fpage>&#x02013;<lpage>875</lpage>. <pub-id pub-id-type="doi">10.1038/nbt0997-871</pub-id><pub-id pub-id-type="pmid">9306402</pub-id></citation></ref>
</ref-list>
<glossary>
<def-list>
<title>Abbreviations</title>
<def-item><term>CSpPNs</term><def><p>corticospinal projection neurons</p></def></def-item>
<def-item><term>EPA</term><def><p>environmental protection agency</p></def></def-item>
<def-item><term><italic>Fezf2</italic></term><def><p>Forebrain embryonic zinc finger 2</p></def></def-item>
<def-item><term>GFP</term><def><p>green fluorescence protein</p></def></def-item>
<def-item><term>IT-PN</term><def><p>intratelencephalic projection neuron</p></def></def-item>
<def-item><term>KEGG</term><def><p>Kyoto encyclopedia of genes and genomes</p></def></def-item>
<def-item><term>LV</term><def><p>lentivirus</p></def></def-item>
<def-item><term>M1</term><def><p>primary motor cortex</p></def></def-item>
<def-item><term>PNs</term><def><p>projection neurons</p></def></def-item>
<def-item><term>PT-PN</term><def><p>pyramidal tract projection neuron.</p></def></def-item>
</def-list>
</glossary>
</back>
</article> 